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Chapter 1 
 
General Introduction 
 
1.1 What is nanoparticle? 
 
   Nanoparticles are generally defined as particles with a diameter of 1-100 nm [1-3]. Ultrafine 
particles with a diameter of 1-10 nm has received attention in the state-of-the-art technology. As 
shown in Fig. 1.1, the size of a nanoparticle are smaller than a virus but larger than a DNA. 
Considering the atomic radius, the number of atoms constituting a nanoparticle is very small. 
Hence the properties of nanoparticles are different from those of their bulk materials [4,5]. The 
surface area to volume ratio of particles, or the ratio of the number of surface atoms to the total 
number of atoms in a particle, increases if the particle size becomes smaller, which causes high 
reactivity (or high catalytic activity) of nanoparticles. In addition, the electronic energy levels 
become discrete in nanoparticles due to the small number of atoms, which is known as quantum 
confinement or quantum size effect, leading to unique electronic and optical properties observed 
in metal or semiconductor nanoparticles. Magnetic properties of nanoparticles are known to 
change by their size such as superparamagnetism and ferromagnetism. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1 Size of nanoparticles as compared to a cell, virus, DNA, and atom. 
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1.2 Ferrite nanoparticle 
 
   Ferrite means the oxides containing ferric ion Fe3+, but ferrite is generally known as the 
magnetic oxides with a spinel structure [6]. Its chemical formula is represented as MO·Fe2O3, 
where M is metal such as Mn, Fe, Co, Ni, Cu, Zn, Mg, etc., or their mixture. In the spinel structure, 
there are two crystallographic sites for M; the one is tetrahedrally coordinated with oxygen (A-
site) and the other is octahedrally coordinated with oxygen (B-site). The unit lattice consists of 
eight A-sites and sixteen B-sites. When 8 A-sites are occupied by M2+ and 16 B-sites are occupied 
by Fe3+, the compound is called a normal spinel type and described as (M2+)A[Fe3+Fe3+]BO4. In the 
case that the A-sites are occupied by Fe3+ and the B-sites are occupied by M2+ and Fe3+, the 
compound is called an inverse spinel type and described as (Fe3+)A[M2+Fe3+]BO4 [6,7]. 
 
 
 1.2.1 Magnetic property 
 
   The mechanism for appearance of magnetism in spinel ferrite nanoparticles is related to 
residual electrons having a spin magnetic moment in 3d orbital (unpaired electrons) in transition 
metal of Sc – Cu. The strength of magnetism, as proposed by Néel, is basically determined by 
two events as follows [6,7]. 
 
(i) The occupation of the tetrahedral A- and octahedral B-sites by transition metal cations (M2+ 
and Fe3+). 
(ii) The orientation of the magnetic moment of cations in A- and B-sites involved with 
interactions between magnetic cations in those sites, namely, A–B, A–A, and B–B 
interactions. 
 
The strength of magnetism (the amount of magnetic moment per unit cell whose lattice 
constant is approximately 8.4 Å) can be estimated using a spin magnetic moment of an electron 
as 1 MB of Bohr magneton, in consideration of antiparallel orientation between the magnetic 
moments of cations in the A-sites and those of cations in the B-sites. For example, the values of 
Fe3O4, MnFe2O4, and NiFe2O4 are calculated to be 32 MB, 40 MB, and 16 MB, respectively, under 
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a condition of inverse spinel structure. These values are approximately consistent with their 
experimental values (32.8 MB, 36.4 MB, and 18.4 MB for Fe3O4, MnFe2O4, and NiFe2O4, 
respectively) [8]. It should be noted that, for CoFe2O4, the experimental value of 31.5 MB [8] is 
exceptionally higher than the value of 24 MB estimated for inverse spinel from Hund’s rule. This 
is derived from the residual orbital magnetic moment of Co2+ ion involved with its electronic 
configuration of d7, which also causes high magnetic anisotropy in CoFe2O4 [9]. For MgFe2O4, 
the value depends on the distribution of Mg2+ ions between A- and B-sites. When all of Mg2+ ions 
occupy the B-site with half of Fe3+ ions to be (Fe3+)A[Mg2+Fe3+]BO4, the magnetization of MgFe2O4 
is calculated to be 0 MB. With an increase in the ratio of Mg2+ occupying A-site, here denoted as 
δ, to a certain extent in the formula of (Mg2+δFe3+1-δ)A[Mg2+1-δFe3+1+δ]BO4, the magnetization also 
increases. At higher δ, the magnetization passes through a maximum value and decreases to zero. 
This is because the A–B interaction becomes weaker with a decrease in the number of magnetic 
Fe3+ ions being substituted by nonmagnetic Mg2+ ions in A-site, which causes antiparallel 
orientation of adjacent magnetic moments in B-sites by the B–B interaction [6]. 
 
The greatest characteristic of magnetic nanoparticles is the dependence of their magnetic 
properties on their diameter [7,10]. Fig. 1.2 shows the relationship between the coercivity and the 
diameter of nanoparticles. Small regions of uniform magnetization in magnetic materials are 
called magnetic domains. The magnetic-domain structure changes with the change of particle 
diameter. There are two states of magnetic domain structure; single- and multi-domain. Because 
magnetic domains have a critical or minimum size, the particles with a diameter smaller than that 
critical size consist of a single magnetic domain. The magnetization process of single-domain 
particles is the magnetization rotation type. The particles with rather large size have a multi-
domain structure, in which magnetic domains are separated by domain walls. The magnetization 
process of multidomain particles is the domain wall motion type. Hence, magnetization reversal 
by domain wall motion does not occur in a particle with single-domain structure. Although the 
domain wall is easily moved by the applied magnetic field, stronger magnetic field is required to 
occur the magnetization rotation. Therefore, single-domain particles have a high coercivity. In the 
diameter range of single domain, the decrease in coercivity is observed as the particle size 
becomes smaller. This is because the influence of thermal disturbance is enhanced relatively. Then, 
the coercivity becomes zero, in which the orientation of magnetic moment is random. This state 
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is called superparamagnetic. 
 
   Fig. 1.2 also showed the example of the biomedical application of Fe3O4 and -Fe2O3 
nanoparticles. For magnetic resonance imaging (MRI) and drug delivery system (DDS), 
superparamagnetic nanoparticles (with a diameter of <20 nm for Fe3O4 and -Fe2O3) are required 
or better because they are intravenously injected into human body. If ferri- or ferromagnetic 
nanoparticles are intravenously injected, there is a risk of forming a blood clot derived from their 
magnetic aggregation. Hence, many researches of superparamagnetic Fe3O4 and -Fe2O3 
nanoparticles are reported for biomedical application. A word of "SPIONs" as an abbreviation of 
superparamagnetic iron oxide nanoparticles has been widely used in recent years. As a 
consequence, superparamagnetic -Fe2O3 nanoparticles has been clinically used as a MRI contrast 
agent: Feridex® and Resovist®. For hyperthermia, both superparamagnetic and ferromagnetic 
nanoparticles are suitable because magnetic nanoparticles are used as heat generators. Which 
magnetic property is more suitable for application to hyperthermia depends on the condition of 
applied AC magnetic field (the strength of magnetic field and the frequency). On the other hand, 
for cell separation, ferromagnetic nanoparticles are required because its objective is to separate 
cells using magnetic force from the mixture of cells and other materials. 
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Fig. 1.2 The relationship between the coercivity (magnetic property) and the diameter of 
nanoparticles, with corresponding examples in biomedical application of Fe3O4 and -Fe2O3 
nanoparticles. 
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1.2.2 Synthetic method 
 
   The synthesis method of nanoparticles can be divided into two types of technique roughly. 
One is the top-down method, and the other is the bottom-up method. In the top-down method, 
nanoparticles are synthesized by breaking large-sized particles but there is a lower limit of the 
particle size synthesized, while effective in mass production. On the other hand, in the bottom-up 
method, nanoparticles are formed from the nucleation and the nucleus growth. This method can 
produce nanoparticles with a diameter range from a few nm to several tens of nm. Additionally, 
it has an advantage of controlling the size and shape, hence the bottom-up method is preferable 
for the synthesis of nanoparticles generally. Here, two types of popular solution phase synthesis 
for ferrite nanoparticles are introduced below.  
 
Co-precipitation method 
 
   In co-precipitation method, an aqueous solution containing a precipitation reagent is added to 
an aqueous solution of the mixture of metal (II) and (III) salts, then nanoparticles are obtained as 
precipitates. The formation of ferrite nanoparticles is progressed by the following reaction 
generally. 
 
M2+ + 2Fe3+ + 8OH− → MFe2O4 + 4H2O.                                     (1.1) 
 
 
 
 
 
 
 
 
Fig. 1.3 Schematic diagram of co-precipitation method. 
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In this method, the size, shape, and composition of products are dependent on the concentration 
ratio of metal salts prepared first. The advantages of this method are following; (i) simple 
synthetic procedure and (ii) it can be synthesized in the atmosphere, while there is a disadvantage 
that the shape is difficult to control. For example, Fe3O4 nanoparticles were synthesized by the 
addition of an aqueous solution containing ammonia as a base into an aqueous solution of the 
mixture of FeCl2 and FeCl3 [11]. 
 
 
Thermal decomposition 
 
   In thermal decomposition, the organometallic salt is decomposed in the presence of a 
surfactant at a high temperature. The surfactant prevents the aggregation of metals. The organic 
solvent with a high boiling point is used because the decomposition occurs at very high 
temperature. The advantage of this synthetic method is to control the shape of particles easily 
with a uniform particle size, while there is a disadvantage of complex synthetic systems in an 
inert gas atmosphere with a high temperature reaction. For example, highly monodisperse Fe3O4 
nanoparticles were obtained by the thermal decomposition of iron (III) acetylacetonate in phenyl 
ether solvent containing alcohol, oleic acid, and oleylamine at 265°C [12]. 
 
 
 
 
 
 
 
 
 
Fig. 1.4 Schematic diagram of thermal decomposition. 
 
 
   Considering the administration of nanoparticles synthesized into human body, those which 
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synthesized by co-precipitation method is more suitable for biomedical application because of its 
hydrophilic property and effective mass production. There is no concern of involving organic 
solvents. 
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1.2.3 Application to hyperthermia 
 
   Hyperthermia (thermotherapy), in which cancer cells are treated with heat of approximately 
43°C [13-15], has recently received attentions as a fourth line of cancer therapy following surgical 
resection, chemotherapy, and radiation therapy. There are three very important advantages for 
hyperthermia: (1) it can be effectively applied to all types of cancer cells, (2) it is non-invasive, 
and (3) it has very few side effects. For example, the Thermotron RF-8 system (Yamamoto Vinita 
Co., Ltd., Osaka, Japan) has been clinically applied to kill cancer cells using heat derived from 8-
MHz radio frequency (RF) irradiation [16,17]. However, achieving cancer cell-specific death is 
difficult in RF-induced hyperthermia because normal tissue is heated along with the cancerous 
tissue. 
 
Recent investigations have focused on the biomedical applications of magnetic nanoparticles 
such as in drug delivery systems, magnetic resonance imaging, and magnetic hyperthermia [18-
35]. In hyperthermia using magnetic nanoparticles and lower frequency (a few hundred kHz) 
magnetic field, just particles generate heat derived from their magnetic property. Hence, if the 
magnetic nanoparticles were to specifically accumulate within a tumor, cancer cells could be 
exclusively heated under an alternating magnetic field; this process is referred to as magnetic 
hyperthermia [18-20,24-28]. Iron oxides such as Fe3O4 or -Fe2O3 nanoparticles are generally 
used as heat generators as they have the advantages of high biocompatibility and relatively large 
magnetization. 
 
Heating mechanism 
 
   The heating mechanism of magnetic nanoparticles under AC magnetic field is classified two 
types. First, superparamagnetic nanoparticles are well known to produce heat that is dependent 
on the amount of magnetic relaxation, consistent with the Néel and Brown relaxation theory, 
under an AC magnetic field [36-39], as shown in Fig. 1.5. 
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Fig. 1.5 Theoretical estimation of heating rates (total heat dissipated through Néel as well as 
Brownian relaxations) as a function of particle diameter. Surfactant layer thickness = 3.2 nm, 
anisotropy constant = 30 kJ m-3, temperature = 300 K, viscosity = 0.00089 kg m-1 s-1, applied AC 
magnetic field = 40 Oe and frequency = 600 kHz. Reprinted with permission from [39]. Copyright 
@ 2009 Elsevier B. V. 
 
 
In contrast, when the ferromagnetic particles are placed under AC magnetic field, heat is 
generated by hysteresis loss [37,38]. For ferromagnetic nanoparticles, the amount of heat 
(hysteresis loss) is dependent on the hysteresis area in M-H loop of particles, as following a 
formula (1.2) [40]. 
 
   Area = 𝑓 ∫𝑀𝑑𝐻                                                        (1.2) 
 
Where f is frequency, M is magnetization, H is magnetic field applied. 
 
   In the latest researches, S. Ota et al. mentioned that the frequency showing highest heating 
efficacy of Fe3O4 nanoparticles was different for each concentration of particles, which suggested 
the involvement of dipole-dipole interaction in heat generation of nanoparticles [41]. 
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Biocompatibility 
 
   Considering to the application of ferrite nanoparticles to hyperthermia (into human body) 
biocompatibility of particles is one of very significant factors. Hence, there are many reports and 
discussion. Of which, L. Moller et al. have carried out in vitro investigation of the cytotoxicity of 
several kinds of oxides nanoparticles in human lung adenocarcinoma epithelial A549 cells [42]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.6 Cytotoxicity in cultured A549 cells after exposure to 20 μg/cm2 (40 μg/mL) and 40 
μg/cm2 (80 μg/mL) nanoparticles for 18 h, measured as percent nonviable cells by trypan blue 
staining. The asterisks (*, **, ***) indicate significantly higher levels compared to controls and 
correspond to p < 0.05, 0.01, 0.001, respectively. Reprinted with permission from [42]. Copyright 
2008 American Chemical Society. 
 
 
As shown in Fig.1.6, CuO and ZnO showed high level of cytotoxicity for A549 cells although, 
iron oxide nanoparticles showed much lower cytotoxicity, especially for Fe3O4 nanoparticles. 
Furthermore, the authors have also investigated the degree of DNA damage induced by the 
addition of nanoparticles, as evaluated by comet assay. As a result, TiO2 showed the high level of 
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DNA damage but no cytotoxicity. On the other hand, Fe3O4 did not showed not only cytotoxicity 
but also induction of DNA damage in their condition, which is suggestive of high biocompatibility 
of Fe3O4 nanoparticles [42]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.7 Hematology and blood chemistry of mice following injection of iron oxide nanoparticles, 
prepared by thermal decomposition with sizes of ~5,~15, or ~30 nm and coated with PEG-
phospholipid, or commercially obtained Feridex (as indicated). Red blood cell number, white 
blood cell number, percentage of neutrophils among white blood cells, hemoglobin concentration, 
hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean 
corpuscular hemoglobin concentration (MCHC) of mice 1, 14, and 30 days after intravenous 
injection with iron oxide nanoparticles (5 mgFe/kg). Statistical analyses were performed with 
Student's t test (*p < 0.05 for the difference between iron oxide nanoparticles and PBS, two-tailed, 
unpaired, n = 4-6, error bars = standard deviation). Reprinted with permission from [43]. 
Copyright 2012 American Chemical Society. 
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   L. Gu et al. has in vivo evaluated the toxicity of iron oxide nanoparticles in blood and organs 
using mice [43]. As shown in Fig. 1.7, iron oxide nanoparticles did not show both toxicity for 
blood cells and damage for blood condition of mice. For organs, iron oxide nanoparticles induced 
no/slight damage in liver and spleen. Therefore, the safety of iron oxide nanoparticles was 
demonstrated in vivo. 
 
In vivo investigation of magnetic hyperthermia 
 
   Here, an instance of in vivo investigation of magnetic hyperthermia is introduced as shown in 
Fig. 1.8. 
 
 
 
 
 
 
 
 
 
 
Fig. 1.8 Anti-cancer immune response induced by hyperthermia using magnetite nanoparticles. 
Rats with tumors on each side of the body were prepared. Particles were injected into the left 
tumor only and the rats were irradiated with an alternating magnetic field. The temperature of the 
left tumor, containing particles (closed circles), increased specifically, whereas the temperature 
of the right tumor (open circles) and rectum (open triangles) remained below 37°C (right panel). 
The tumor-specific hyperthermia treatment induced an anti-tumor immune response and both 
tumors disappeared on the 28th day after hyperthermia treatment. (I) Control rat without 
alternating-magnetic-field irradiation; (II) rat with alternating-magnetic-field irradiation. Open 
triangle in (I) and (II), the side without particles; closed triangle in (I) and (II), the side with 
particles. Adapted with permission from [44]. Copyright @ 2011 John Wiley & Sons, Inc. 
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T. Kobayashi reported that the tumor volume in mice was reduced with showing very high 
reduction rate when the tumor with Fe3O4 nanoparticles modified with cationic liposome were 
exposed to AC magnetic field [44]. Furthermore, the other side of tumor without Fe3O4 
nanoparticles which was not observed temperature increase, has reduced because of activation of 
immune cells after the treatment of hyperthermia (remote effect). Therefore, ferrite nanoparticles 
show promise for magnetic hyperthermia [44]. 
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1.2.4 Previous studies 
 
   T. Osaka and his group have been investigated the synthesis of Fe3O4 nanoparticles and their 
in vitro evaluation for magnetic hyperthermia previously. 
 
   First, they demonstrated the synthesis of Fe3O4 nanoparticles with the size tuned in the range 
of approximately 10 to 40 nm in mean diameter by chemical reaction in an aqueous solution 
containing iron(II) and iron(III) salts at various ratios with 1,6-hexanediamine as a base as shown 
Fig. 1.9 [45].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.9 Dependence of mean diameter of Fe3O4 nanoparticles on the molar percentage of ferrous 
ions in the total amount of iron ions. Reprinted with permission from [45]. Copyright @ 2007 
Elsevier B. V. 
 
 
The size of Fe3O4 nanoparticles was controlled by the preparation molar ratio of Fe2+ to Fe3+. 
When the ratio of Fe2+ to Fe3+ was 1:2, 10-nm Fe3O4 nanoparticles were obtained via the famous 
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reaction (1.3). On the other hand, 40-nm Fe3O4 nanoparticles were obtained at the ratio of 1:0. In 
the mechanism of forming 40-nm Fe3O4 nanoparticles, three different reactions are suggested to 
be progressed as shown (1.4)-(1.6) [45-47]. Here organic amines are considered to serve not only 
as a base but also as a protective reagent. Magnetic properties of Fe3O4 nanoparticles can be 
controlled by the particle diameter [45]. 
 
Fe2+ + 2Fe3+ + 8OH− → Fe3O4 + 4H2O.                                      (1.3) 
Fe2+ + 2OH− → Fe(OH)2.                                                 (1.4) 
   3Fe(OH)2 + 1/2O2 → Fe(OH)2 + 2FeOOH + H2O.                              (1.5) 
   Fe(OH)2 + 2FeOOH → Fe3O4 + 2H2O.                                      (1.6) 
 
Second, they developed the synthetic method of Fe3O4 nanoparticles with positive charge 
using spermine, or N,N'-bis(3-aminopropyl)butane-1,4-diamine, as a base and a protective reagent 
instead of 1,6-hexanediamine [48]. Then, the percentage of breast cancer cells containing 
nanoparticles was compared for Fe3O4 nanoparticles synthesized with spermine or 1,6-
hexanediamine. As a result, higher percentage was observed for Fe3O4 nanoparticles with 
spermine (positive charge) than those with 1,6-hexanediamine (negative charge) as shown in Fig. 
1.10.  
 
 
 
 
 
 
 
 
 
Fig. 1.10 Confocal microscopic images of human breast cancer MCF-7 cells after the incubation 
with two types of magnetite nanoparticles synthesized with spermine (left) and 1,6-
hexanediamine (right). The indicated percentages mean the percentage of cells containing 
nanoparticles. Reprinted with permission from [48]. Copyright @ 2009 Elsevier B. V. 
Spermine 81% 1,6-hexanediamine 23%
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The mechanism of cellular uptake of nanoparticles is generally known to be endocytosis, whose 
process is classified with three steps: (i) accumulation of nanoparticles onto cell surface, (ii) 
invagination cell membrane with nanoparticles, and (iii) enclosing nanoparticles inside cells 
(forming endosome). Since cell surface is negatively charged, the adsorption of positively charged 
nanoparticles onto cell surface is easier than negatively charged nanoparticles in the step (i), 
which induced higher percentage of cells containing nanoparticles and larger uptake amount of 
nanoparticles per a cell [48]. 
 
   Third, considering to biomedical application, Fe3O4 nanoparticles were evaluated for their 
safety by normal cells (mouse embryonic stem: mES cells) from the viewpoint of viability and 
damage of cell function [49]. As shown in Fig. 1.11, the viability of mES cells was approximately 
100% at the dose range of 0 – 1000 g/mL, and the ratio of undifferentiated cells was not altered 
when culturing with Fe3O4 nanoparticles. Therefore, the high safety of Fe3O4 nanoparticles was 
demonstrated using normal cells. 
 
 
 
 
 
 
 
 
 
 
Fig. 1.11 Dose dependent of viability of mES cells.Fe3O4 nanoparticles were added to mES (0, 
125, 250, 500, 750, 1000 g/mL). mES cells were incubated for 24 h and stained by propidium 
iodide, and then viability was determined by flow cytometry (left) and the ratio of undifferentiated 
cells. mES and mES with added Fe3O4 nanoparticles were stained (right). Reprinted with 
permission from [49]. Copyright @ 2012 Elsevier B. V. 
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Fig. 1.12 Living rate of MCF-7 without (-) and with (+) magnetic irradiation at the dose of 700 
g. Reprinted with permission from [50]. Copyright @ 2012 Elsevier B. V. 
 
With human breast cancer MCH-7 cells, they compared the effect of 10-nm 
(superparamagnetic) and 40-nm (ferromagnetic) Fe3O4 nanoparticles on induction of cell death 
under AC magnetic field. Consequently, ferromagnetic Fe3O4 nanoparticles showed higher cell 
mortality than superparamagnetic nanoparticles, as shown in Fig. 1.12 [50]. 
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1.3 My approach of nanoparticles design for magnetic hyperthermia 
 
   There has already been a beneficent clinical report of implant magnetic hyperthermia with 
FePt needles for the treatment of tongue cancer in 1996 [51]. Hence, magnetic hyperthermia is 
expected to become a useful cancer therapy, but there is no beneficent clinical report for the 
treatment of cancer located in human body. For the treatment of tumor with a diameter of 5 mm, 
at least 650 g/cm3 of magnetic nanoparticles is estimated to be needed. However, accumulation 
of nanoparticles into tumors at the concentration of >650 g/cm3 is difficult. Furthermore, 
superparamagnetic nanoparticles such as commercial iron-oxide nanoparticles of Feridex® and 
Resovist® being clinically used as MRI contrast agents are suitable for the administration into 
human body (intravenous injection) although, they has been reported to show too low heating 
efficacy to induce cell death effectively [39,50,52]. Also, they are poorly taken up by cells [53]. 
In this situation, accumulation of nanoparticles to tumors can be achieved by a direct injection 
of nanoparticles into tumors on/under the human skin, and into tumors situated deep in the body 
using a catheter. Moreover, nanoparticles can be obtained the selectivity of cancer cells by 
modification with a cancer-selective material. However, there is room for improvements in the 
design of nanoparticles for enhancing the therapeutic effect. In particular, the control of magnetic 
properties of nanoparticles appropriate to the applied condition of AC magnetic field for an 
increase in the heating efficacy of nanoparticles is a key issue for practical use of magnetic 
hyperthermia. 
   In this background, employing ferromagnetic nanoparticles as a heat generator of magnetic 
hyperthermia is considered in my approach, to overcome the issue. There is little concern of 
forming a blood clot by directly injecting nanoparticles into tumors using a catheter. 
   In this thesis, taking advantages of the results found by T. Osaka and his group as mentioned 
in the section 1.2.4, 10- and 40-nm Fe3O4 nanoparticles were synthesized by co-precipitation 
(hydrolysis) method with an organic amine as a base and a protective reagent. 10- and 40-nm 
Fe3O4 nanoparticles were employed to obtain superpara- and ferromagnetic nanoparticles. As an 
organic amine, spermine was employed with expectation of an enhancement in cellular uptake of 
nanoparticles by their positive charge.  
The applied condition of AC magnetic field is also important for the design for effective 
magnetic hyperthermia. In this thesis, considering to the coercivity of 40-nm Fe3O4 nanoparticles 
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which has been reported to be approximately 100-200 Oe [45,50], the strength of applied 
magnetic field on the induction-heating device was set to 536 Oe. In this case, the effective 
strength of magnetic field is assumed to be around 200-300 Oe. The applied condition of AC 
magnetic field for medical care was defined by the International Commission on Non-Ionizing 
Radiation Protection, which is < 5 × 109 A∙m-1∙s-1 of a product of magnetic field amplitude and 
frequency. Generally, higher frequency induces larger heat generation in magnetic hyperthermia. 
Considering to the effective strength of magnetic field in this thesis (200-300 Oe), the maximum 
frequency in the range of the definition is estimated to be around 300 kHz. Therefore, 325 kHz of 
frequency was employed in this thesis. 
In the design of nanoparticles for effective magnetic hyperthermia, there are two major 
significant points to achieve the objective. 
 
(i) To understand the interactions (influence) between nanoparticles and cells 
(ii) To control magnetic and surface properties of nanoparticles 
 
Based on the point (i), using synthesized 10-nm and 40-nm Fe3O4 nanoparticles (MNPs) with 
positive charge, induction of cell death by MNPs in mesothelioma cells was investigated in 
Chapter 2. Malignant mesothelioma is a tumor situated deep part of human body with little 
effective treatment. Then, taking advantages of the findings of Chapter 2, surface design of MNPs 
and their effect on melanoma tumor in mice was also investigated in Chapter 3. Melanoma was 
employed because the method of making tumor into mice has been established and magnetic 
hyperthermia can be easily applied to tumors located on/under human skin, in principle. 
Based on the point (ii), control of magnetic properties of MFe2O4 (M = Co, Mg) nanoparticles 
for increase in heating efficacy was focused in Chapter 4, as a study leading to the future 
technology. Furthermore, through the investigation of the effect of MFe2O4 nanoparticles 
synthesized on breast cancer cells, the advantages of each ferrite nanoparticles was compared and 
discussed. Breast cancer cells were also employed because magnetic hyperthermia can be easily 
applied to tumors located on/under human skin. 
As an example of applications of ferrite nanoparticles, magnetic cell separation using 40-nm 
ferromagnetic Fe3O4 nanoparticles and microalgae was discussed in Chapter 5. Microalgae were 
employed because effective cell separation is required for practical commercialization of 
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microalgal biomass production. 
   Overall, from the viewpoint of control of magnetic properties, this thesis aimed to contribute 
as a recipe to material engineering approach for the practical use of ferrite nanoparticles to 
magnetic hyperthermia. 
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Chapter 2 
 
Induction of cell death by Fe3O4 nanoparticles in mesothelioma cells 
 
2.1 Introduction 
 
   The objective and motivation of this chapter is to understand the interactions (influence) 
between nanoparticles and cells in detail, using mesothelioma cells. 
 
   With regard to a magnetic design of MNPs, 10-nm superparamagnetic and 40-nm 
ferromagnetic MNPs were employed in this study to compare magnetic properties of MNPs for 
effective induction of cell death. The 40-nm ferromagnetic MNPs were reported to have higher 
heating capacity under AC magnetic field rather than 10-nm MNPs [1]. As for surface design of 
MNPs, spermine which possess positively charged moiety was employed as a base and a 
protective reagent in the synthetic process of MNPs in co-precipitation (hydrolysis) [2], in order 
to enhance MNPs incorporation into cells [3]. 
 
   Malignant pleural or peritoneal mesothelioma is an aggressive tumor that develops after 
asbestos exposure [4-7]. The mechanism of mesothelioma development is still unknown, but it 
has been newly suggested that iron overload in the mesothelial tissue is a key in asbestos 
(chrysotile, crocidolite, and amosite)-induced mesothelial carcinogenesis [8]. There are three 
histological subtypes (epithelioid, sarcomatoid, and biphasic) in mesothelioma from the 
differences of cell morphology and surface proteins [7,9]. Around 60% of total mesothelioma 
patients are categorized as “epithelioid”, 20% are “sarcomatoid” patients, and the others are 
classified as “biphasic” [9]. In mesothelioma diagnosis, according to a report from the National 
Cancer Institute, physical exam and history, chest X-ray, CT scan, and biopsy are generally used 
[10]. 
 
   The World Health Organization (WHO) has reported that 92,253 people mesothelioma deaths 
were recorded in 83 countries for the period of 1994 to 2008 [11]. It should be emphasized here 
that mesothelioma treatment still have a major worldwide problem [5,8,9-15]. Primary treatment 
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of mesothelioma is surgical resection [5,8,9,16], radiation therapy [5,8], and chemotherapy 
[5,8,9,17]. However, survival rates are very low because mesothelioma is usually situated deep in 
the body and is resistant to chemotherapeutic agents. The median overall survival of 
mesothelioma patients with no treatment was 4.1 months (95% confidence interval, 3.4-4.8). But 
even if those were treated, the median overall survival was still low such as 15.1 (12.0-19.0) with 
both radical surgery and systemic chemotherapy, 8.6 (6.6-10.5) with radical surgery but no 
systemic chemotherapy, and 9.3 (8.4-10.2) with systemic chemotherapy but no radical surgery 
[9]. Moreover, surgical removal is invasive and chemotherapy has negative side effects. Although 
multimodal therapy combining two or more treatments, is proposed to improve the survival rate 
and quality of life [3,16-18], the most effective combination is still contested. Therefore, more 
effective treatments for mesothelioma, for prolonging survival or effecting a cure, are strongly 
required. 
 
   To overcome the issue, nanoparticle uptake and cell death induced by the addition of MNPs 
were evaluated in three histological types of human mesothelioma cells, i.e. NCI-H28 
(epithelioid), NCI-H2052 (sarcomatoid), and MSTO-211H (biphasic) cells, and the future 
application of MNPs to mesothelioma treatment is considered in this chapter. This study described 
here represents the first investigation of cellular uptake and cytotoxicity of MNPs in three 
histological cell types, in addition to their cell death induced by MNPs subjected to alternating 
magnetic field. 
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2.2 Experimental 
 
Cell culture 
 
   Human mesothelioma NCI-H28, NCI-H2052, and MSTO-211H cells (American Type Culture 
Collection) were maintained in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO) containing 
10% fetal bovine serum (FBS; ThermoFisher Scientific, Waltham, MA) and 1% penicillin-
streptomycin (Sigma-Aldrich). Human breast cancer MCF-7 cells were cultured in Eagle’s 
minimum essential medium (EMEM; Sigma-Aldrich) with 10% FBS, 5% L-glutamine 
(Invitrogen, Life Technologies, Grand Island, NY), 1% MEM non-essential amino acid (Gibco, 
Life Technologies), and 1% antibiotic-antimycotic (Gibco). All cells were incubated at 37°C 
under a 5% CO2 atmosphere. Cell condition of MSTO-211H was evaluated by analysis of 
incubation-time dependence of cell productivity and by fluorescence-observation of actin-
staining cells using an F-Actin Visualization Biochem Kit™ (Cytoskeleton, Inc.) according to the 
manufacturer’s protocol. 
 
Synthesis and characterization of magnetite nanoparticles (MNPs) 
 
   MNPs were synthesized by hydrolysis of an aqueous solution containing ferrous chloride 
(FeCl2·4H2O) and ferric chloride (FeCl3·6H2O), using essentially the same procedure as described 
in a literature [2], except for the use of spermine, or N,N'-bis(3-aminopropyl)butane-1,4-diamine, 
as a base instead of 1,6-hexanediamine. Iron salts and spermine were purchased from Kanto 
Chemical Co. Ltd. (Tokyo, Japan) and Sigma-Aldrich Japan, respectively. 50 mL of an aqueous 
solution containing ferrous chloride and ferric chloride at a molar ratio of 2:1 (for 10-nm MNPs) 
or 1:0 (for 40-nm MNPs), the total amount of which was 0.05 mol dm-3, was mixed with 50 mL 
of an aqueous solution containing 0.125 mol dm-3 of spermine, and the mixture was stirred at 
room temperature. After stirring for 24 h (for 10-nm MNPs) or 4 h (for 40-nm MNPs), the black 
precipitate was separated using a permanent magnet and washed several times with ultrapure 
water and ethanol. The final products were obtained, in the form of a black powder, after drying 
in a desiccator at room temperature. The shape and size of the products were observed by 
transmission electron microscopy (TEM) with a JEOL JEM-1011 microscope (Tokyo, Japan) or 
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a Hitachi H-7650 microscope (Tokyo, Japan) operated at an acceleration voltage of 100 kV. The 
mean diameter of products were calculated using a following equation after counting and 
measuring diameters (Dn) of one hundred nanoparticles in TEM images.  
 
Mean diameter =
(𝐷1+𝐷2+𝐷3+⋯+𝐷100)
100
                                         (1) 
 
The crystal structure of the products was characterized by X-ray diffraction (XRD) patterns 
recorded using a RINT ULTIMA III diffractometer (Rigaku, Tokyo, Japan) with Cu K radiation 
(1.5418 Å). The zeta potential and hydrodynamic diameter of the specimens dispersed in water at 
around pH 7 were evaluated using an Otsuka Electronics ELS-8000 light-scattering photometer 
(Osaka, Japan). 
 
Evaluation of cytotoxicity and cellular uptake 
 
   NCI-H28, NCI-H2052, MSTO-211H, and MCF-7 cells were cultured in 6-well plates at a 
density of 5 × 105 cells per 3 mL of medium in each well, and then incubated without or with 10-
nm MNPs at 200, 400, 600, and 800 g per well. After incubation for 24 h, the cells were washed 
with Dulbecco’s phosphate buffered saline (DPBS; Gibco) to remove excess MNPs. The 
morphology of MSTO-211H and MCF-7 cells was observed using a Nikon TE2000-U microscope 
(Tokyo, Japan). Cell pellets were obtained by centrifugation at 1200 rpm for 5 min, and suspended 
in 1 mL of DPBS supplemented with 6% FBS, followed by staining with 2 L of 42 μM thiazole 
orange (TO) in dimethyl sulfoxide and 1 L of 4.3 mM propidium iodide (PI) in water. TO and 
PI were purchased from BD Biosciences, Becton, Dickinson and Co. (Franklin Lakes, NJ) as part 
of the BD Cell Viability Kit. Immediately following this treatment, the cells were analyzed with 
a BD FACSCanto II flow cytometer. PI stains dead cells only, whereas TO stains both living and 
dead cells. Dead cells were recognized by their PI-positive response and cells were distinguished 
from MNPs by TO positive staining. Cellular uptake of MNPs was measured using side scatter 
(SSC) section. The ratio of cells containing MNPs to the total number of cells was determined in 
the following way. In a flow cytometer, light scattering occurs when a cell deflects incident laser 
light. The scattered light is collected as forward scatter (FSC) and SSC. The SSC depends on the 
inner complexity of the cell because SSC measures refracted and reflected light at a side angle to 
 30 
 
Chapter 2 
the laser path. Therefore, high values along the SSC axis would indicate that the cells contained 
MNPs. To discuss the cellular uptake of MNPs, TEM observation of NCI-H28, NCI-H2052, and 
MSTO-211H incubated with 800 g of MNPs was performed at the Hanaichi UltraStructure 
Research Institute Co., Ltd. (Aichi, Japan) with a JEOL JEM1200EX at an acceleration voltage 
of 80 kV. To prepare specimens for TEM observation, cells were washed with 0.1 M phosphate 
buffer, fixed with 2% osmium tetroxide, dehydrated with 50–100% ethanol, embedded in 
EPON812, and finally sectioned using an ultramicrotome. The amount of MNPs incorporated into 
a NCI-H28, NCI-H2052, or MSTO-211H cell was evaluated using a literature-described 
procedure [16,19]. HCl, trichloroacetic acid solution, H2O2, and potassium thiocyanate solution 
were used to dissolve cells with MNPs, to precipitate the cellular proteins, to oxidize Fe2+ into 
Fe3+, and to form a thiocyanate-iron(III) complex; finally, the absorbance at 480 nm was measured 
using a JASCO V-550 spectrophotometer (JASCO International Co. Ltd., Tokyo, Japan). 
 
Detection of DNA fragmentation in apoptotic cells 
 
   MSTO-211H cells were cultured at a density of 5 × 105 per well in the presence of 800 g of 
10-nm MNPs as described above. After 24-h incubation, a DNA fragmentation assay was 
performed using a Quick Apoptotic DNA Ladder Detection Kit (Invitrogen) according to the 
manufacturer’s protocol. After extraction of chromosomal DNA, DNA fragmentation was 
analyzed by agarose gel electrophoresis. The DNA fragments were viewed under UV light and 
photographed. 
 
Microarray analysis 
 
   NCI-H28, NCI-H2052, and MSTO-211H cells were cultured for 24 h at the density of 5 × 105 
per well in the presence of 800 g MNPs as described above. Total RNA isolation and gene 
expression microarrays were performed at Cell Innovator Inc. The total RNA was isolated from 
cerebellums of each individual animal using TRIzol Reagent (Invitrogen) and purified using SV 
Total RNA Isolation System (Promega) according to the manufacturer’s instructions. Gene 
expression microarray was performed using Agilent SurePrint G3 Human Gene Expression 
Microarray 8 × 60K v2. The cRNA was amplified and labeled using Agilent Low Input Quick 
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Amp Labeling Kit, and hybridized to a 60K Agilent 60-mer oligomicroarray according to the 
manufacturer’s instructions. All hybridized microarray slides were scanned by an Agilent scanner. 
Relative hybridization intensities and background hybridization values were calculated using 
Agilent Feature Extraction Software (9.5.1.1). Microarray data of samples were normalized by 
quantile algorithm. 
 
Evaluation of cell death with MNPs subjected to alternating magnetic field. 
 
   MNPs with a diameter of 40 nm, such as ferromagnetic MNPs, were employed here.  
Prior to the experiments using MNPs and cells, heating capacity of MNPs was investigated. 
To evaluate the heating capacity of MNPs, a sample which contains 1.0 mg of MNPs dispersed 
in 500 μL of water or fixed in 500 μL of 1% agarose gel was subjected to AC magnetic field 
induced using a device of EASYHEAT (Alonics, Ltd., Tokyo, Japan) including a 3-turn coil with 
an outside diameter of 40 mm, at a frequency of 325 kHz with a current of 569.1 A for 20 min. 
By making use of above values for estimation of the strength of magnetic field, that is calculated 
to be 536 Oe. During exposure, the temperature of sample was recorded every a second with an 
Anritsu FL-2000 fiber thermometer (Tokyo, Japan), and cooling water was circulated in the coil 
using a DC inverter chiller RKE1500B1-V (Nagano, Japan) to prevent the influence of the heat 
from coil to the temperature of a sample. Specific adsorption rates (SARs) were determined from 
the slope between 0 and 100 s in the recorded temperature curves using parameters of specific 
heat capacity (Cpi) and mass for each substance (mi) or MNPs (mMNPs), by a following equation. 
 
SAR =
∑ 𝐶𝑝𝑖𝑚𝑖𝑖
𝑚𝑀𝑁𝑃𝑠
∙
∆𝑇
∆𝑡
                                                     (2) 
 
A magnetization curve at the magnetic field of -10000 to 10000 Oe at 300 K was measured 
using a BHV-35 vibrating sample magnetometer (VSM; Riken Denshi Co. Ltd., Tokyo, Japan). 
 
   In this section, 5 × 105 or 1 × 105 of NCI-H28 and MSTO-211H cells or NCI-H2052 cells, 
which were cultured to adhere for 24 h in advance, were incubated for further 24 h with MNPs at 
concentrations of 0, 133, 267 μg/mL, respectively. Cell numbers cultured with MNPs were 
determined considering cell condition such as viability and density of cells after 48-h cultivation. 
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   The MNPs-containing 5 × 105 cells collected by magnetic separation were dispersed in 500 
μL of medium and then subjected to 20 min of AC magnetic field (325 kHz, 500 Oe) with 
measuring the sample temperature every a second. Cell mortality immediately after exposure to 
AC magnetic field was evaluated by cell counting with trypan blue (TB; Gibco) staining. Prior to 
the exposure also, cell mortality of samples was evaluated. Live cells are TB negative, whereas 
dead cells are TB positive, hence cell mortality was calculated by a following formula. 
 
   Cell mortality (%) =
𝐶𝑜𝑢𝑛𝑡𝑠 𝑜𝑓 𝑇𝐵 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
𝐶𝑜𝑢𝑛𝑡𝑠 𝑜𝑓 𝑎𝑙𝑙 𝑐𝑒𝑙𝑙𝑠
× 100                          (3) 
 
The percentage of non-viable cells, which was evaluated by cell counting after the 20 min of 
exposure to AC magnetic field, was compared with that evaluated after 20-min heating using a 
THERMAL ROBO TR-1A thermostatic water bath (AS ONE Corporation, Osaka, Japan). 
Temperatures in thermostatic bath were set on the average temperatures between 800 and 1200 s 
obtained from the temperature curves of samples exposed to AC magnetic field. 
Time course of cell mortality after the exposure of cells containing MNPs to AC magnetic 
field was also investigated. After exposure, the cells were incubated for further 24 h at 37°C under 
a 5% CO2 atmosphere. Same experiment was performed on the cells containing MNPs without 
exposure to AC magnetic field. Cell morphology after the 24-h incubation was observed using a 
Nikon TE2000-U microscope (Tokyo, Japan). The mode of cell death was evaluated by flow 
cytometric analysis using a PE Annexin V Apoptosis Detection Kit I (BD Pharmingen)  
according to the manufacturer’s protocol. 
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2.3 Characterization of Fe3O4 nanoparticles 
 
   Fig 2.1 shows TEM images, histograms of particle size distribution, and XRD patterns of the 
MNPs employed in this study. TEM observation showed that particle shape and size were 
consistent with a previous report [16-19]. One hundred nanoparticles were counted to determine 
their size distribution; the mean particle diameters were 10.3 ± 1.7 and 42.7 ± 8.9 nm, shown in 
Fig. 2.1B and D, respectively. The XRD patterns of the samples (Fig. 2.1E) matched the standard 
pattern of Fe3O4 (JCPDS# 19-629) and the d value of the lattice spacing of (311) was calculated 
to be 2.528 and 2.534 Å for (a) and (b), respectively, using the Bragg equation for the peak 
observed at 2θ ~ 36°. The calculated values were concordant with the standard value for Fe3O4 of 
2.532 Å (JCPDS# 19-629), not with the value for γ-Fe2O3 of 2.518 Å (JCPDS# 39-1346), similar 
to a previous report [2]. The zeta potentials of 10-nm and 40-nm MNPs, measured in water at 
around pH 7, were +10.7 and +16.8 mV, respectively, which is attributable to the cationic form of 
the amine groups in spermine adsorbed on the surface of the nanoparticles as a protecting reagent 
[3]. To consider the state dispersed in solution, the size distribution of MNPs in ultrapure water 
was evaluated by the light scattering method. The size distribution of 10-nm and 40-nm MNPs in 
ultrapure water suggests the formation of an aggregation or secondary particle with a 
hydrodynamic diameter of approximately 1 m. The interaction among the protecting agent, 
spermine in the present study, may contribute to form secondary particles in water. Additionally, 
from TG analysis, the contribution of spermine molecules to the weight of samples was evaluated 
as much as 9.6 weight percent for each specimen, which was comparable to the mass fraction (5 
wt%) calculated from the model for monolayer adsorption of spermine on 10-nm MNPs by using 
values of theoretical surface-to-volume ratio, density, and formula weight. 
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Fig. 2.1 Characterization of the MNPs employed in this study. TEM images (A,C) and size 
distribution (B,D) of “10-nm” MNPs (A,B) and “40-nm” MNPs (C,D). XRD patterns with Cu 
K radiation (E) of “10-nm” MNPs (a) and “40-nm” MNPs (b). Reprinted with Permission. 
Copyright 2015 American Chemical Society. 
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2.4 Effect of addition of nanoparticles on cellular uptake and cell death 
 
   First, the morphology of MSTO-211H and MCF-7 cells cultured without and with the addition 
of 10 nm MNPs was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.2 Cell morphology of MSTO-211H (A, B) and MCF-7 (C, D) cells after incubation for 24 
h without (A, C) and with (B, D) MNPs. In B and D, 200 μg of 10-nm MNPs were administered 
to 5  105 cells. Scale bar: 50 μm. Reprinted with Permission. Copyright 2015 American 
Chemical Society. 
 
 
Fig. 2.2 shows an optical microscopic image of MSTO-211H cells incubated for 24 h without 
MNPs. A mixture of spindle-like cells (mainly in Fig. 2.2A) and polygonal cells (partly in Fig. 
2.2A), which is characteristic of biphasic mesothelioma MSTO-211H cells, was observed. The 
spindle-like cells formed multilayers and were in cell-cell contact. In contrast, after 24 h of 
incubation with 200 μg of MNPs, some of the MSTO-211H cells shrunk to a needle like shape. 
MSTO-211H cells treated with MNPs were confirmed to have lower adhesive capacity than the 
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control cells (Fig. 2.2B). In contrast, no morphological differences were observed between MCF-
7 cells incubated without (Fig. 2.2C) and with 200 μg of MNPs (Fig. 2.2D). At a high dose (800 
μg) of MNPs, more MSTO-211H cells appeared shrunken than at a dose of 200 μg, although the 
large number of MNPs rendered observation difficult. It should be noted that, prior to the addition 
of MNPs, the MSTO-211H cells were in satisfactory condition for experiments, based on the 
results shown in Fig. 2.3. The number of MSTO-211H cells was kept almost constant at the 
incubation time from 0 to 24 h, then increased drastically at the incubation time between 24 and 
48 h (Fig. 2.3A). This cell-growth behavior suggests that these cells were normal and healthy and 
the experiment was carried out at the proper period in the cell cycle. As shown Fig. 2.3B, the actin 
stress fibers existed throughout the cell before the addition of MNPs, suggesting that the cell 
condition is preferable to the experiment. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.3 Characterization of MSTO-211H cells without the addition of MNPs: the incubation time-
dependence of cell productivity (A) and the fluorescent image of rhodamine phalloidin stained 
cells (B). Scale bar 25 μm. 
 
 
   Since the shrinkage of human mesothelioma MSTO-211H cells following the addition of 
MNPs was observed, unlike other cell types in the previous studies [1,2,19], the specific cytotoxic 
effect of MNPs on mesothelioma cells was then investigated. Fig. 2.4A shows the dose 
dependence of the percentage of non-viable cells, as evaluated by flow cytometry, with the 
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addition of 0, 200, 400, 600, and 800 μg of MNPs to mesothelioma NCI-H28, NCI-H2052, and 
MSTO-211H cells and breast cancer MCF-7 cells (5  105 cells for each treatment). Dose-
dependent cell death was observed in MSTO-211H cells; at a dose of 200 μg, 20% non-viable 
cells were observed, reaching 50% at a dose of 800 μg. In contrast, the percentage of non-viable 
MCF-7 cells remained constant (4%) at doses ranging from 0 to 800 μg. It should be noted here 
that, among the mesothelioma cells, the response of epithelioid NCI-H28 and sarcomatoid NCI-
H2052 cells differed from that of biphasic MSTO-211H cells. The percentage of non-viable NCI-
H28 cells remained almost constant, as low as 10%, at doses ranging from 0 to 800 μg, whereas 
the percentage of non-viable NCI-H2052 cells slightly but gradually increased with the dose, from 
5% at a dose of 200 μg to 15% at doses of 600 μg and 800 μg. As mentioned in detail in next 
chapter, cellular uptake of MNPs induces slight cell damage such as the change of intracellular 
ROS and cell cycle distribution, which caused a little higher cell mortality of NCI-H2052 cells 
than NCI-H28 and MCF-7 cells. The dependence of cell death on the incubation time was also 
investigated in MSTO-211H cells, at a dose of 800 μg MNPs as shown in Fig. 2.5. The percentage 
of non-viable MSTO-211H cells gradually increased with the incubation time, from 5% at 2 h to 
50% at 24 h; the percentage of non-viable control cells, without MNPs, remained below 8% with 
incubation times ranging from 2 h to 24 h.  
   Fig. 2.4B shows the ratio of the number of cells containing MNPs to the total number of cells, 
as evaluated by flow cytometry, under conditions similar to those in Fig. 2.4A. The percentage of 
cells containing MNPs was shown to increase gradually as the MNPs dose increased for both 
MSTO-211H and MCF-7 cells; it reached 70% and 90% for MSTO-211H and MCF-7 cells, 
respectively, at a dose of 800 μg of MNPs. The percentage of NCI-H28 and NCI-H2052 cells 
containing MNPs, in contrast, reached 80% even at a dose as low as 200 μg. 
   As a check of the interaction between MNPs and normal cells, the effect of addition of MNPs 
on human umbilical vein endothelial cells (HUVEC) was also investigated. As a result, although 
the percentage of uptake was 80%, no more than 10% cell mortality wad observed at doses 
ranging from 0 to 800 μg. Therefore, it was suggested the possibility that MNPs are safe to normal 
cells. 
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Fig. 2.4 Dependence of the percentage of non-viable cells (A) and the percentage of cells 
containing MNPs (B) on the amount of 10-nm MNPs added to 5 × 105 NCI-H28 cells (diamonds), 
NCI-H2052 cells (squares), MSTO-211H cells (circles), and MCF-7 cells (triangles). Reprinted 
with Permission. Copyright 2015 American Chemical Society. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.5 Dependence of the percentage of non-viable MSTO-211H cells on the incubation time at 
a dose of 800 μg of MNPs (diamonds) and without MNPs (circles) in 5 × 105 cells. 
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To understand the cellular uptake of MNPs in more detail, the state and amount of MNPs 
incorporated in a single cell for the three types of mesothelioma cells were examined. TEM 
images (Fig. 2.6) revealed that (i) MNPs were incorporated into cells as aggregates and (ii) MNPs 
were not present in the nucleus but were present in the cytoplasmic endoplasmic reticulum in all 
three types (A: epithelioid NCI-H28, B: sarcomatoid NCI-H2052, and C: biphasic MSTO-211H 
cells). The images shown in Fig. 2.6 are representative of multiple TEM images not shown here 
for each cell types. These results are similar to previous observations for human breast cancer 
MCF-7 cells [3]. On the other hand, several differences were observed among the three 
histological types, e.g. in the size of the vesicles (endosomes) containing the MNPs and the 
density of MNPs in these vesicles. Fig. 2.7 shows the dose dependence of the uptake of MNPs by 
mesothelioma cells. In all three mesothelioma cell types, the quantity of MNPs incorporated per 
cell increased linearly with the dose of MNPs; 150 pg and 650 pg of MNPs were incorporated per 
cell at doses of 200 μg and 800 μg, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.6 TEM images of a NCI-H28 cell (A), a NCI-H2052 cell (B), and a MSTO-211H cell (C) 
containing MNPs. Reprinted with Permission. Copyright 2015 American Chemical Society. 
 
 
   It should be noted that the percentage of cells containing MNPs increased with the MNPs dose 
not only in MSTO-211H but also in MCF-7, NCI-H28, and NCI-H2052 cells (Fig. 2.4), and the 
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amount of MNPs incorporated per cell increased linearly with the dose for all three types of 
mesothelioma cells (Fig. 2.7). Thus, the cytotoxic effect of MNPs appears to be specific to 
biphasic mesothelioma cells. Brunner et al. investigated the in vitro cytotoxicity of oxide 
nanoparticles using MTT and Hoechst assays, and showed that MSTO-211H cells were highly 
sensitive to Fe2O3, while 3T3 cells were not greatly affected [20]. Although they speculated that 
the high sensitivity of MSTO compared to 3T3 cells could be attributed to a higher phagocytotic 
activity of MSTO cells than that of 3T3 cells, the reasons for this cell type-specific response 
remain unclear. This study is the first to find that MNPs show distinct in vitro cytotoxicity in 
MSTO-211H (biphasic) cells, among three histologic mesothelioma subtypes. From Fig. 2.4A and  
B, although the percentage of non-viable cells tended to be lower than that of MNPs-containing 
cells, both percentages gradually increased as the dose increased, suggesting a certain relationship 
between cell death and cellular uptake of MNPs.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.7 Dependence of the amount of MNPs incorporated per cell on the amount of 10-nm MNPs 
added to 5 × 105 NCI-H28 cells (diamonds), NCI-H2052 cells (squares), and MSTO-211H cells 
(circles). Reprinted with Permission. Copyright 2015 American Chemical Society. 
 
 
   Next, the mode of cell death was investigated. Fig. 2.8 shows the results of the DNA 
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MSTO-211H cells incubated with MNPs (Lane 3), whereas control MSTO-211H cells without 
addition of MNPs did not show either laddering or smearing (Lane 2). This result provides 
evidence for the occurrence of apoptotic DNA fragmentation in MSTO-211H cells after 
incubation with MNPs. The appearance of DNA ladders is related to the endonuclease activation 
with subsequent cleavage of DNA into nucleosomal fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.8 DNA fragmentation analyzed by 1.2% agarose gel electrophoresis: the 1-kb DNA ladder 
marker (Lane 1), control MSTO-211H cells without addition of MNPs (Lane 2), and MSTO-211H 
cells after 24 h of incubation with 10-nm MNPs (Lane 3). Reprinted with Permission. Copyright 
2015 American Chemical Society. 
 
 
   To consider why only MSTO-211H cells showed high rates of cell death, differences in gene 
expression between without and with the addition of MNPs in three types of mesothelioma cells 
were examined. As shown in Fig. 2.9, transforming growth factor-beta2 (TGF-β2) was observed 
to overexpress specifically in MSTO-211H cells; 43-fold up-regulation of TGF-β2 was observed 
in MSTO-211H cells treated with MNPs, whereas TGF-β2 expression was unaltered by addition 
of MNPs in NCI-H28 and NCI-H2052 cells. TGF-β2 is reported to have physiological activities 
including induction of apoptosis, involving generation of reactive oxygen species (ROS) [21,22]. 
1 2 3
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Schuster et al. explained that the apoptotic process is accompanied by two phases of generation 
of ROS: a rapid and a delayed phase after TGF- administration, in the reference [21] and Yao et 
al. demonstrated experimentally that TGF-β2-induced apoptosis in human lens epithelial cells is 
preceded by an enhancement in ROS production in the reference [22]. Therefore, the specific cell 
death to MSTO-211H is considered to associate with the ROS generation. Hence detecting ROS 
using a Total ROS Detection Kit (Enabling Discovery in Life Science®) was carried out in this 
study, but failed; valid data to discuss the difference in ROS generation among cell types have not 
been obtained yet unfortunately. It should be noted that the mode of cellular uptake and the 
intracellular location and state of incorporated MNPs, observed by TEM (Fig. 2.6), were similar 
in all three histological types. Therefore, the overexpression of TGF-β2 caused by the addition of 
MNPs is suggested to result in the induction of apoptosis specific to MSTO-211H cells. Although 
the reason for cell-type specific overexpression of TGF-β2 has not been elucidated, it is 
interesting to note that Khan et al. reported that uptake of MNPs affects the TGF-β signaling 
pathway in HeLa cells [23]. There is else a literature that iron oxide nanoparticles induce ROS 
formation, which disrupts the actin cytoskeleton and alters endothelial cell morphology and 
mechanics, as well as induction of cell death [24]. In this study also, the decrease in the amount 
of actin stress fiber and the change of their morphology were observed for MNPs-added cells (Fig. 
2.10), as compared with control cells as shown in Fig. 2.3B. 
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Fig. 2.9 Expression level of TGF-β2 in all three histological types of human mesothelioma cells 
(NCI-H28, NCI-H2052, and MSTO-211H) cultured without and with 10-nm MNPs. The control 
signal intensity was set to “1.” Reprinted with Permission. Copyright 2015 American Chemical 
Society. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.10 Rhodamine Phalloidin stained mesothelioma MSTO-211H cells after 24-h incubation 
with MNPs at the dose of 200 μg (A) and 800 μg (B). Scale bar 25 μm. 
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2.5 Exposure of cells containing nanoparticles to alternating magnetic field 
 
   40-nm MNPs were employed here because ferromagnetic MNPs with a diameter of 40 nm 
were shown to be much more effective for inducing cell death of MCF-7 cells, by their heat 
generation under an AC magnetic field (325 kHz, 500 Oe), than superparamagnetic MNPs with a 
diameter of 10 nm in the previous paper [1]. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.11 Time dependence of the temperature curve of 1 mg MNPs dispersed in 500 μL of water 
under an AC magnetic field (325 kHz, the strength was calculated to be 500 Oe) (A) and a 
magnetization curve of MNPs at the magnetic field of -10000 to 10000 Oe at 300 K (B). 
 
 
   At first, characterization of 40-nm MNPs in terms of heating capacity was investigated. Fig. 
2.11A shows the time dependence of temperature reached under AC magnetic field and the field 
dependence of magnetization at 300 K. Average temperature reached at the exposure time during 
800 – 1200 s and the SAR at the time of 100 s were calculated to be 63°C and 792 W/g for a 
liquid sample. From the magnetization curve as shown in Fig. 2.11B, 40-nm MNPs was observed 
to show ferromagnetic behavior with a magnetization at 10000 Oe of approximately 90 emu/g 
and a coercivity of 200 Oe. The temperature rise of 40-nm MNPs in solid matrix under alternating 
magnetic field was also investigated. In solid condition, physical rotation of nanoparticles is 
restricted, consequently occurs no Brownian relaxation. However, the SAR of solid sample at the 
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time of 100 s, which was calculated to be 1076 W/g, is similar to that of liquid sample. Therefore, 
it is suggested that this MNPs generate heat steadily in a solid such as intracellular environment 
because the heat is produced by hysteresis loss, not Brownian relaxation. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.12 Amount of MNPs incorporated by a NCI-H28 (blue), NCI-H2052 (green), and MSTO-
211H (red) cell at the MNPs concentrations of 133 and 267 μg/mL (A), and the percentage of 
cells containing MNPs at the concentrations of 67, 133, 200, and 267 μg/mL (B). 
 
 
   Fig. 2.12A shows uptake amount of MNPs into a cell. The dependence on MNPs concentration 
was observed in all types of mesothelioma cells, but those values were different among each types. 
At the concentration of 133 or 267 μg/mL, 500 or 900 pg of MNPs was incorporated into a NCI-
H28 and NCI-H2052 cell, whereas 200 or 400 pg was incorporated into a MSTO-211H cell, 
respectively. Referring to the previous paper [3], cellular uptake seems to occur via the adsorption 
of nanoparticles onto cells with attractive forces between positive charge of MNPs (the zeta 
potential was +16.8 mV) and negative charge of cell surface. Fig. 2.12B shows the percentage of 
cells containing MNPs analyzed with flow cytometry. Uptake percentage increased with an 
increase in MNPs concentration for MSTO-211H, it was 40% at 67 μg/mL and reached 70% at 
267 μg/mL. On the other hand, 70% of NCI-H28 and NCI-H2052 cells contained MNPs at the 
concentration of 67 μg/mL. At 267 μg/mL, uptake percentage showed 70% for NCI-H28 and 
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90% for NCI-H2052, respectively. This tendency, which is the dose dependence of uptake 
percentage, corresponded with not only the tendency of uptake amount shown in Fig. 2.12A but 
also the tendency of the percentage of cells containing 10-nm MNPs as shown in Fig. 2.4B. 
 
   Next, the cells containing MNPs were subjected to AC magnetic field whose strength of 
magnetic field was calculated to be 500 Oe at a frequency of 325 kHz for 20 min in all cell types 
of mesothelioma. The average temperature during 800 – 1200 s in the vicinity of the cells 
containing MNPs was shown in Table 2.1. Although the temperatures of cells cultured without 
MNPs maintained 30°C in whole exposure time, the dose dependence of temperature rise was 
observed in all types of mesothelioma cells containing MNPs, suggesting intracellular heating by 
40-nm MNPs. The reached temperature was different among histological types because the 
intracellular amount of MNPs was also different for each cell types as shown in Fig. 2.12A. 
 
 
Table 2.1 Average temperature between 800 and 1200 s in the vicinity of the cells containing 
MNPs under AC magnetic field (325 kHz, 500 Oe) for 20 min.  
 
 
 
 
 
 
 
   To investigate the effect of intracellular heating by MNPs on death of mesothelioma cells, the 
cell mortality induced by heat generated from MNPs was compared with that induced by 
thermostatic bath. In thermostatic water bath, cell death was induced by extracellular heating. Fig. 
2.13 shows the comparison of cell mortality induced by intracellular heating with extracellular 
heating in three types of mesothelioma cells. At the MNPs concentration of 267 μg/mL, the 
percentage of non-viable cells containing MNPs with alternating magnetic field was 
approximately 95% for NCI-H28, 100% for NCI-H2052, and 90% for MSTO-211H, respectively. 
On the other hand, at the same condition except for the use of thermostatic bath instead of 
NCI-H28 NCI-H2052 MSTO-211H
0 31±1 32±1 31±1
133 42±1 46±1 35±1
267 51±1 56±1 40±1
Dose (g/mL)
Average Temperature(ºC)
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alternating magnetic field, cell mortality was lower: approximately 40% for NCI-H28, 50% for 
NCI-H2052, and 30% for MSTO-211H. At 133 μg/mL, the mortality was lower than those for 
267 μg/mL although, higher cell mortality was also observed for intracellular heating than 
extracellular heating in all cell types. There is a literature that “intracellular” is effective because 
the cell membrane works as an excellent thermal barrier and a very poor thermal conductor [25], 
which suggested that the temperature in the cells is higher than the observed temperature 
(temperature of suspension). As mentioned in the section 2.4, cellular uptake of MNPs causes 
slight cell damage such as the change of intracellular ROS and cell cycle distribution. 
Consequently, the cells then become more sensitive to intracellular heat. It should be noted that 
intracellular heating by MNPs internalized into cells was found to induce cell death effectively in 
all cell types of mesothelioma. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.13 The percentage of non-viable NCI-H28 (A), NCI-H2052 (B), and MSTO-211H (C) at 
the MNPs concentrations of 0, 133, and 267 μg/mL. “In thermostatic bath (purple bars)” means 
without AC magnetic field, but those temperatures are set on the average temperature between 
800 and 1200 s shown in Table 2.1 using a water bath. Other bars indicate the data obtained with 
AC magnetic field (325 kHz, 500 Oe). The cell mortalities in all samples were evaluated 
immediately after heating. 
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h time interval of incubation at 37°C was investigated in all histological types of mesothelioma 
cells as shown in Fig. 2.14. Here, Fig. 2.14A, B, and C show the percentage of non-viable cells 
containing MNPs without alternating magnetic field. As observed in Fig. 2.4A, dose-dependent 
cell death was observed in MSTO-211H cells but not in NCI-H28 and NCI-H2052 cells even after 
just magnetic separation in Fig. 2.14A-C. The cell-type-specific cell death should also be related 
to the overexpression of transforming growth factor 2 induced by MNPs as shown in Fig. 2.9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.14 The percentage of non-viable NCI-H28 (A,D), NCI-H2052 (B,E), and MSTO-211H 
(C,F) at the MNPs concentrations of 0, 133, and 267 μg/mL without (A-C) or with (D-F) an AC 
magnetic field (325 kHz, 500 Oe). The data shown as “I0” and “I24” means the cell mortalities 
measured immediately or after 24 h of incubation at 37°C following just magnetic separation (A-
C) or exposure to alternating magnetic field (D-F). 
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Following further 24-h incubation, 1.5 – 2 times of increase in mortality was observed in NCI-
H28 and MSTO-211H, whereas the mortality of NCI-H2052 cells was increased by 3 – 5 times. 
High sensitivity of mesothelioma cells to incorporated MNPs could induce higher mortality. As 
shown in Fig. 2.4A, the percentage of non-viable cells in the presence of MNPs was compared 
for three types of mesothelioma cells and human breast cancer MCF-7 cells, resulting that the 
percentage of all types of mesothelioma cells was >2 times higher than MCF-7 cells. 
 
   When the cells after subjecting to alternating magnetic field were further incubated at 37°C 
for 24 h, the cell mortalities in all condition except for with no MNPs increased as shown in Fig. 
2.14D, E, and F, it reached approximately 100% in all three histological types of mesothelioma 
cells at the MNP concentration of 267 μg/mL. 
 
   At the time, cell morphology at the different concentrations of MNPs in three types of 
mesothelioma cells was also observed by an optical microscopy as shown in Fig. 2.15. With no 
MNPs, NCI-H28 cells were adhered with elongated spindle shape, NCI-H2052 were adhered with 
cubic-like or polygonal shape, and MSTO-211H cells were adhered with a mixture of those shapes. 
On the other hand, cells with MNPs were not adhered and its rate increased with a dose amount 
in all types of mesothelioma, which corresponded approximately to the percentages of cell death 
(Fig. 2.13D-F). At 267 μg/mL, approximately 100% of cells were floating with a small spherical 
shape. In mesothelioma therapy, it is a very significant issue that surviving cancerous cells or 
tumors resume their proliferation soon after a treatment. However, no standard treatment 
approaches have been proven to improve survival or control symptoms for a prolonged period of 
time [26]. Notably, the results from Figs. 2.14 and 2.15 demonstrated that the treatment of 
exposure of the cells containing MNPs to AC magnetic field has a potential to inhibit the 
secondary cancer-cell proliferation in all three histological subtypes of mesothelioma in vitro, 
which is suggestive of the recurrence prevention in mesothelioma treatment. 
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Fig. 2.15 Microscopic images of NCI-H28 (A,D,G), NCI-H2052 (B,E,H), and MSTO-211H 
(C,F,I) cells with the MNPs concentrations of 0 (A,B,C), 133 (D,E,F), and 267 (G,H,I) μg/mL 
incubated for 24 h under the condition of 37°C and 5% CO2 after exposure to alternating magnetic 
field (325 kHz, 500 Oe). Scale bar: 200 m. 
 
 
   To consider the influence of intracellular heating with incorporated MNPs on cell death in 
mesothelioma, the mode of cell death of NCI-H2052 with MNPs subjected to alternating magnetic 
field was discussed. Fig. 2.16 shows the cell dot plots with PE Annexin V on the x-axis and 7-
AAD on the y-axis, as evaluated by flow cytometry. In the plot, viable cells are PE Annexin V 
and 7-AAD negative (lower left quadrant, Q3), cells that are in early apoptosis are PE Annexin V 
positive and 7-AAD negative (lower right quadrant, Q4), and cells are in late apoptosis or are 
already dead are PE Annexin V and 7-AAD positive (upper right quadrant, Q2). Almost all NCI-
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H2052 cells without MNPs (Fig. 2.16A,D) located in Q3. NCI-H2052 cells with MNPs 
immediately after the magnetic field exposure located in Q3 and Q2, which is indicative of the 
induction of necrosis (Fig. 2.16B,C). In general, cell death by heating is known to be induced by 
both apoptosis and necrosis via DNA damage in a temperature-dependent manner [27,28]. 
Compared Fig. 2.16B with E, it was understood that the cell group located in Q3 in Fig. 2.16B 
right transferred to Q4, which should suggested that apoptosis was undergone in 24-h incubation 
at 37°C following exposure to alternating magnetic field, but the location of cell group in Q3 in 
control (Fig. 2.16D) was not altered after 24-h incubation. For NCI-H2052 cells at the 
concentration of 267 μg/mL, all cells were categorized already dead cells, which is equivalent to 
the percentages of cell death (Fig. 2.14D-F). 
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Fig. 2.16 Detection of apoptotic NCI-H2052 cells with MNPs and with alternating magnetic field 
(325 kHz, 500 Oe), as evaluated by flow cytometry: upper and lower dot plots shows the data 
measured immediately (A-C) or after 24 h of incubation at 37°C (D-F) following exposure to 
alternating magnetic field. The inserted table is the summary of flow cytometric results. 
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2.6 Conclusion 
 
   With an objective to understand the interactions (influence) between nanoparticles and 
mesothelioma cells, cellular uptake and cytotoxicity of MNPs in three histological types of 
mesothelioma cells (i.e. epithelioid NCI-H28, sarcomatoid NCI-H2052, and biphasic MSTO-
211H), in addition to their cell death induced by MNPs subjected to AC magnetic field were 
investigated and discussed in this chapter. 
 
   As a new finding, cell death by the addition of MNPs was observed in MSTO-211H cells 
without applying AC magnetic field. Both NCI-H28 and NCI-H2052 cells were not induced death 
by MNPs. Cellular uptake of MNPs was observed in all cell types. The ratio of the number of 
cells containing MNPs to the total number of cells was shown to depend on the dose of MNPs, 
which for MSTO-211H was lower than that for other three cell types. DNA fragmentation and 
microarray analyses suggested that MNPs induced transforming growth factor-beta2-related 
apoptosis in MSTO-211H cells.  
 
   When AC magnetic field was applied to NCI-H28, NCI-H2052, and MSTO-211H cells 
containing MNPs, temperature rose under the AC magnetic field, and high rates of cell death were 
observed in all three histological types of mesothelioma. Furthermore, cell viabilities became 
much lower (approximately 0%) by letting the cells containing MNPs incubate at 37°C for 24 h 
after exposure to alternating magnetic field in all cell types. Because higher cell mortality was 
observed when cells are heated by incorporated MNPs with an alternating magnetic field as 
compared to thermostatic-bath heating, significance of cellular uptake of MNPs to induce cell 
death efficiently in mesothelioma has been demonstrated.  
 
   The results of the in vitro experiments performed in this study demonstrated the potential of 
MNPs for future application to mesothelioma treatment via the following two approaches: (i) the 
use of the specific apoptotic effect of MNPs on MSTO-211H cells and (ii) use of heat generation 
by MNPs subjected to an AC magnetic field, which induced a high degree of cell mortality in all 
three major histologic subtypes of mesothelioma cells. The 10-nm MNPs could be applied to the 
former approach, whereas the 40-nm MNPs show particular promise for the latter. 
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Chapter 3 
 
Effect of cellular uptake of Fe3O4 nanoparticles (MNPs) on breast cancer 
cell death in vitro and surface design of MNPs for in vivo application in 
melanoma 
 
3.1 Introduction 
 
   In section 3.2, to confirm the importance of cellular uptake for effective magnetic 
hyperthermia, the influence of the location of nanoparticles (i.e., intracellular or extracellular) on 
cell condition was investigated in breast cancer cells. In section 3.3, surface design 
(functionalization) as well as control of magnetic properties of Fe3O4 nanoparticles to show 
therapeutic effect to melanoma tumors was discussed. Breast cancer and melanoma were 
employed since magnetic hyperthermia can, in principle, be easily applied to tumors located 
on/under the human skin. Melanoma was used into mice because the method of making tumor 
has been established. 
 
   In 1979, Gordon et al. demonstrated in vivo for the first time that the intracellular heating 
using submicron iron oxide particles was more effective than extracellular heating in magnetic 
hyperthermia because the cell membrane works as an excellent thermal barrier and a very poor 
thermal conductor [1]. After that, the effectiveness of intracellular heating with the use of 
magnetic nanoparticles that were internalized by cells has been further discussed in vitro [2-5]. 
Although the ref. [2] and [3] said that there was no difference in the thermal sense between two 
systems of heating methods, the intracellular heating led to enhanced reduction in cell viability 
rather than the extracellular heating in the ref. [4] and [5]. Also in the chapter 2, the intracellular 
heating by magnetite nanoparticles induced death of three histological subtypes of mesothelioma 
cells effectively. In this situation, two systems consisting of human breast cancer MCF-7 cells and 
40-nm magnetite nanoparticles (MNPs) was investigated in the section 3.2: the one is the cells 
with MNPs addition, and the other is the cells pre-cultivated for 24 h in the presence of MNPs. 
The former essentially contains extracellular MNPs, and the latter contains both intracellular and 
extracellular MNPs. A comparison of the two systems should be meaningful considering actual 
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situation. By comparing two systems, the effect of intracellular and extracellular MNPs on MCF-
7-cells condition was examined, in view of influence associated with cellular uptake of MNPs. In 
addition, the effect of the heating with MNPs exposed to alternating magnetic field on cell death 
was compared with that of the heating by thermostatic water bath. 
 
   From the results of chapter 2 and section 3.2, the significance of cellular uptake of MNPs to 
induce cell death efficiently has been demonstrated in vitro. In section 3.3, taking advantage of 
the in vitro results, in vivo application of MNPs with designed surface property and controlled 
magnetic property was investigated. This study is the collaboration research with Catholic 
University of Korea (Prof. Kun Na group). 
 
   In the control of magnetic property of MNPs, considering to using AC magnetic field with a 
frequency of 112 kHz with a strength of magnetic field of 250 Oe, superparamagnetic 10-nm 
MNPs were employed in this study. If ferromagnetic 40-nm MNPs are used as a heat generator at 
this applied condition, heat could not be generated efficiently. Because the coercivity of 40-nm 
MNPs is higher than the strength of effective magnetic field applied, their magnetization reversal 
rarely occurred. 
 
   In the surface design of MNPs, to increase of therapeutic efficacy associated with increase in 
cellular uptake, the selectivity to cancer cells were modified on the surface of MNPs. Recently, 
there are many reports of surface modification of MNPs with a cancer-selective molecule [6-18]. 
R. Rastogi et al. reported folate conjugated iron oxide nanoparticles for targeting cancer cells [8]. 
Folate receptor is known to be overexpressed on many of cancer tumor cells [6-8]. However, 
folate conjugated nanoparticles are incorporated into normal cells because normal cells also 
possess folate receptor. On the other hand, T. Chen et al. reported the aptamer conjugated Fe3O4 
nanoparticles [11], of which aptamer (single-oligonucleotide chain) can specifically bind to the 
receptor located on cancer cells [11-13]. Although specific to cancer cells, there is a concern of 
ambiguous in vivo kinetics. Based on these backgrounds, hyaluronic acid (HA) was employed in 
this study, since HA has advantages of (i) high biocompatibility [14], (ii) high hydrophility [15], 
and (iii) high cancer tumor targeting efficacy [16,17]. HA can bind specifically bind to the HA 
receptor (CD44) located on cancer cells such as melanoma. In this study, HA was acetylated in 
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order to become lower its solubility [15]. 
 
   Furthermore, to increase in therapeutic efficacy, pheophorbide-a (a photodynamic therapeutic 
agent; PheoA) was modified onto MNPs. PheoA generates reactive oxygen species when exposed 
to the light with a wavelength of 671 nm [15]. In this study, magnetic hyperthermia combined 
with photodynamic therapy discussed. Although drug delivery system is generally selected as the 
other therapy in magnetic hyperthermia combined with other therapy [8,11], this study focused 
on photodynamic therapy due to their ability of not only treatment but also imaging using 
fluorescence of PheoA.  
 
   Overall, superparamagnetic 10-nm MNPs which modified with PheoA-conjugated acetylated 
hyaluronic acid (AHP@MNPs) were designed to achieve effective treatment of cancer. 
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3.2 Influence of intracellular and extracellular nanoparticles in vitro 
 
3.2.1 Experimental 
 
Synthesis of magnetite nanoparticles 
 
MNPs with a diameter of 40 nm were synthesized from ferrous chloride (FeCl2·4H2O) and 
1,6-hexanediamine (H2N(CH2)6NH2) as reported in the paper [18]. Both chemicals were 
purchased from Kanto Chemical Co., Inc. Briefly, 100 mL of an aqueous solution containing 0.05 
mol/L of ferrous chloride was mixed with 100 mL of an aqueous solution containing 0.25 mol/L 
of 1,6-hexanediamine, and the mixture was stirred for 24 h at room temperature. Afterwards, the 
black precipitates were washed with ultrapure water and ethanol, and vacuum dried to make them 
powder before use in other experiments. 
 
MCF-7 cell cultivation 
 
MCF-7 cells were cultured in Eagle’s minimum essential medium (EMEM; Sigma-Aldrich) 
with 10% fetal bovine serum (FBS; Thermo Fisher Scientific), 5% L-glutamine (Invitrogen), 1% 
MEM non-essential amino acid (Gibco), and 1% antibiotic-antimycotic (Gibco). The cells were 
incubated at 37°C in an atmosphere with 5% CO2. 
 
Preparation of two systems consisting of cells and MNPs for comparison 
 
   Two systems consisting of MCF-7 cells and MNPs were prepared: the one is the cells with 
MNPs addition (hereinafter referred to as “simply-added” system), and the other is the cells pre-
cultivated for 24 h in the presence of MNPs (hereinafter referred to as “pre-cultivated” system). 
Regarding the “simply-added” system, a 500-µL suspension containing a mixture of cells and 
MNPs was prepared with adding 0, 125, or 250 µg of MNPs to 5 × 105 MCF-7 cells suspended 
in the medium using the 1.5-mL microtube.  
As for the “pre-cultivated” system, MCF-7 cells were seeded in a 6-well dish at a density of 
5 × 105 cells per 3 mL of medium in each well and then cultivated with MNPs at the dose of 0, 
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125, or 250 µg per well for 24 h at 37°C. After the pre-cultivation with MNPs, cells were harvested 
by a treatment with 0.25 % trypsin-EDTA. It should be noted that basically neither aspiration nor 
rinse were performed to avoid the loss of MNPs; the amount of MNPs in this “pre-cultivated” 
system should be the same as that in the “simply-added” system for comparison. After 
centrifugation, the whole of MNPs and cells collected was resuspended in 500 µL of medium 
using the 1.5-mL tube. 
 
Cell cycle analysis and detection of reactive oxygen species after cellular uptake of MNPs 
 
Cell proliferation in the “pre-cultivated” system was investigated by using FlowCellect 
Bivariate Cell Cycle Kit for DNA Replication Analysis (Millipore) and DNase I reagent (Sigma 
Aldrich) for flow cytometric analysis. Cells were labeled and stained with bromodeoxyuridine (5-
bromo-2'-deoxyuridine, BrdU) and propidium iodide (PI) according to essentially the same 
protocol as provided by manufacturer (Millipore). BrdU incorporated in newly synthesized DNA 
in cells was stained with anti-BrdU antibodies conjugated to Alexa Fluor 488 and total DNA in 
cells was stained by PI/RNase solution. Flow cytometric analysis was performed with a BD 
FACSCanto II flow cytometer. 
 
   The generation of reactive oxygen species (ROS) was detected by using CellROX Green 
Reagent (Thermo Fisher Scientific). For the evaluation of “pre-cultivated” system, 5 × 105 MCF-
7 cells were cultivated with 0, 125, or 250 µg of MNPs for 24 h at 37°C. After removing 
unincorporated MNPs, 0.5 μL of 2.5 mmol/L CellROX Green Reagent was added. Cells were 
incubated for 30 min followed by washing three times with DPBS, and then observed with an 
Olympus BX51 fluorescence microscope. N-acetyl-L-cysteine as the ROS inhibitor and 
pyocyanin as the ROS inducer were used for negative and positive controls, respectively. In 
contrast, for evaluating “simply-added” system, a 200-μL portion of the 500-µL suspension 
containing a mixture of 5 × 105 MCF-7 cells and 0, 125, or 250 µg of MNPs was dispensed to a 
cuvette with slide glass and they were centrifuged (600 rpm, 3 min) with a Thermo Scientific 
Cytospin 4 cytocentrifuge. The cells on the slide glass were treated with 0.5 μL of 2.5 mmol/L 
CellROX Green Reagent for 30 min, followed by washing three times with DPBS. The sample 
on the slide glass was observed with the fluorescence microscope. 
 61 
 
Chapter 3 
Exposure cells with MNPs to an alternating magnetic field 
 
   Samples in the 1.5-mL microtubes, which were prepared as described above, were exposed to 
an alternating magnetic field (AMF) with an output power of 4.3 kW and an electric current of 
569.1 A at a frequency of 325 kHz for 20 min, using an Alonics EASYHEAT induction-heating 
device equipped with a 3-turn coil with an outer diameter of 40 mm. The strength of magnetic 
field was calculated to be 536 Oe. During the 20-min exposure to the alternating magnetic field, 
sample temperature was measured with an Anritsu FL-2000 fiber thermometer by inserting the 
head of an FS600-2M fiber probe into the sample (cell suspension) in the 1.5-mL tube. 
 
   Samples in the 1.5-mL microtubes, which were prepared as described above, were also treated 
at constant temperature for 20 min by being placed in an AS ONE Corporation THERMAL 
ROBO TR-1A water bath. 
 
   Cell mortality immediately or after 24 h of incubation at 37°C following exposure to AMF 
was evaluated by cell counting with trypan blue (TB; Gibco) staining. 
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3.2.2 Influence associated with cellular uptake of nanoparticles 
 
To consider how cellular uptake of MNPs affects cellular condition, cell cycle distribution 
was examined in the “pre-cultivated” system. As shown in Fig. 3.1, the increase and decrease in 
the percentage of cells in the G1 and S phase, respectively, was observed when incubated in the 
presence of MNPs. At higher dose of MNPs, the change in the percentage was greater. Thus this 
change in cell cycle distribution seems to be associated with cellular uptake of MNPs. The cell 
cycle arrest in the G1 phase, often accompanied by cellular uptake of nanoparticles, has been 
reported for MNPs in L929 murine fibroblast cells [19] and in A549 human lung adenocarcinoma 
cells [20]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1 Percentages of cells in G1, S, and G2/M phases for the MCF-7 cells cultivated for 24 h 
in the presence of 0, 125, and 250 µg MNPs. G1 is the phase of preparation for DNA synthesis 
(growth), S is the phase of DNA replication, G2 is the phase of preparation for mitosis (growth), 
and M is the phase of cell division. 
 
 
   Next, intracellular ROS was examined by fluorescence microscopy; the samples for 
observation were treated with the cell-permeable reagent, which is essentially non-fluorescent 
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while in a reduced state but exhibits a strong fluorogenic signal upon oxidation. Fig. 3.2 shows 
bright field (A-C) and fluorescence (D-F) microscopic images of the MCF-7 cells pre-cultivated 
for 24 h in the presence of MNPs, corresponding to the “pre-cultivated” system. From Fig. 3.2D-
F, a change (an increase) in fluorescence intensity was observed for the samples cultivated with 
MNPs, particularly at higher dose of MNPs. Similar tendency was reported for J774 murine 
macrophage [21] and for A549 cells [22] with iron oxide nanoparticles.  
The change in intracellular ROS as well as cell cycle distribution described above could be 
evidences for cell injury or damage to some degree resulting from cellular uptake of MNPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2 Bright field (A-C) and fluorescence (D-F) microscopic images of MCF-7 cells pre-
cultivated for 24 h in the presence of (A,D) 0, (B,E) 125, and (C,F) 250 µg of MNPs. 
 
  
A B C
D E F
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3.2.3 Cell death induced by intracellular or extracellular heating 
 
   Fig. 3.3 shows the ratios of the number of viable cells measured at 0 and 24 h after 20-min 
exposure to an alternating magnetic field to the initial number of viable cells. Here “AMF” 
represents the time immediately after the magnetic field application and “AMF+I24” indicates 
the time after 24-h incubation at 37°C subsequent to the magnetic field application. The initial 
number of viable cells, Nvc,initial, was measured just before the magnetic field application.  
For the sample in the absence of MNPs (control), of which temperature remained at 
apprximately 37°C under the alternating magnetic field, only a slight decrease and 1.4-fold 
increase in the number of viable cells were observed at “AMF” and “AMF+I24”, respectively, in 
both systems. It should be mentioned here that the difference between two systems in the absence 
of MNPs is simply the difference in the incubation period. The increments in viable cell counts at 
“AMF+I24” were slightly smaller than the results after 24-h incubation in the preceding section, 
which were contributable to a certain damage caused by the operation for magnetic field 
application.  
In contrast, for the samples in the presence of MNPs, the decrease in the number of viable 
cells was observed at “AMF” and a further decrease was observed at “AMF+I24”. With 125 µg 
of MNPs, with the temperature rise to 45°C under the alternating magnetic field, the reduction in 
the viable cell count to approximately 0.8 times of the initial count was observed at “AMF” in 
both systems. At “AMF+I24”, the ratio of Nvc/Nvc,initial decreased to 0.5 and 0.4 in “simply-added” 
and “pre-cultivated” systems, respectively. With 250 µg of MNPs, with the temperature rising to 
52°C, a decrease in the number of viable cells to 0.6 and 0.1 times of the initial number was 
observed at “AMF” and “AMF+I24”, respectively, in the “simply-added” system. More clearly 
in the “pre-cultivated” system, the ratio of Nvc/Nvc,initial was reduced to 0.1 even at “AMF” and to 
as low as 0.05 at “AMF+I24”.  
The cell death induced by MNPs subjected to the alternating magnetic field was found to 
appear earlier in “pre-cultivated” system than in “simply-added” system. Considering the results 
described in the section 3.2.2, there is a possibility that the presence of intracellular MNPs or the 
cellular uptake of MNPs causes (slight) cell damage, and then MCF-7 cells internalizing MNPs 
become sensitive to heat (temperature rise).  
Through this chapter and the section 2.5, significance of cellular uptake of MNPs to induce 
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cell death efficiently has been demonstrated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3 Ratios of the number of viable cells measured at 0 and 24 h after 20-min exposure to an 
alternating magnetic field to the initial number of viable cells for (a) “simply-added” and (b) “pre-
cultivated” systems. “AMF” represents the time immediately after the exposure to alternating 
magnetic field and “AMF+I24” indicates the time after 24-h incubation at 37°C subsequent to the 
magnetic field application. 
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3.3 Surface design of MNPs suitable for in vivo application 
 
3.3.1 Experimental 
 
This study is the collaboration research with Catholic University of Korea (Prof. Kun Na 
group) [23]. 
 
Synthesis of AHP@MNPs 
 
   MNPs with a diameter of 10 nm were synthesized by the same method described in the chapter 
2. AHP was prepared according to a report [15]. Those MNPs an AHP were mixed and sonicated 
in water at a weight ratio of 1 to 1. The molecular weight of HA (obtained from Bioland Co., 
Cheonan, Korea) is 5.8 kDa. PheoA was purchased from Frontier Scientiﬁc (Logan, UT). 
 
Cellular uptake and cell death study in vitro 
 
   Mouse embryonic fibroblast NIH3T3 and murine melanoma K1735 cells (American Type 
Culture Collection, USA) were used. AHP@MNPs at the concentration of 3-50 µg/mL were 
added to 1 × 105 NIH3T3 and K1735 cells. After washing with PBS, cellular uptake of 
AHP@MNPs was observed by a fluorescent microscope. Nuclei of cells were stained with DAPI 
(colored blue). AHP@MNPs was colored red derived from PheoA. 
   When AHP@MNPs at MNPs concentration of 12 µg/mL were added to 2 × 104 NIH3T3 and 
K1735 cells, the samples after washing with PBS were exposed to He-Ne laser with a wavelength 
of 671 nm and AC magnetic field with a frequency of 112 kHz with a strength of magnetic field 
of 250 Oe. Cell viability was evaluated by MTT assay. 
 
In vivo study of accumulation to tumor and therapeutic effect of AHP@MNPs 
 
   For the melanoma tumor developed after the injection of K1735 cells into mice, AHP@MNPs 
at the amount of 0.01 mmol/kg of MNPs were intravenously injected into the mice. Then, the 
accumulation of AHP@MNPs to tumor was observed by a fluorescent microscope, and the 
tumors were exposed to He-Ne laser with a wavelength of 671 nm at 200 mW/cm2 for 500 s and 
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AC magnetic field with a frequency of 112 kHz with a strength of magnetic field of 250 Oe for 
30 min. Therapeutic effect was evaluated by measuring tumor size before/after the exposure. It 
should be noted here that all animal experiments were approved by the Institutional Animal Care 
and Use Committee (IACUC) of the Catholic University of Korea (Republic of Korea) in 
accordance with the “Principles of Laboratory Animal Care”, NIH publication no. 85-23, revised 
in 1985, according to K. S. Kim et al. [23]. 
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3.3.2 Results and discussion 
 
   The schematic diagram of this study was shown in Fig. 3.4. 
 
 
 
 
 
 
 
 
Fig. 3.4 Schematic diagram of this study. Hyaluronic acid is used as a tumor targeting molecule 
and pheophorbide-a is used as a photosensitizer. 
 
 
   First of all, it should be noted here that AHP was successfully modified on the surface of 
MNPs with attractive electrostatic interaction between positive charge of spermine and negative 
charge of hyaluronic acid with pheophorbide-a. The AHP@MNPs showed high dispersibility in 
water because of their high hydrophility derived from HA [23]. 
 
   Using NIH3T3 and K1735 cells, cellular uptake of AHP@MNPs was evaluated. NIH3T3 cells 
are normal cells, whereas K1735 cells are cancer cells. Hence, CD44 is overexpressed on K1735 
cells not on NIH3T3 cells. After the addition of AHP@MNPs to the medium containing cells, 
cellular uptake of AHP@MNPs was observed in CD44-positive K1735 cells, while CD44-
negative NIH3T3 cells did not take up AHP@MNPs, according to the fluorescent images reported 
by K. S. Kim et al. [23]. Hence, AHP@MNPs was suggested to be incorporated into cells through 
CD44 receptor-mediated endocytosis, and the ability of cancer targeting of AHP@MNPs was 
expected.  
 
   As a result, when cells incubated with AHP@MNPs were exposed to He-Ne laser with a 
wavelength of 671 nm and AC magnetic field with a frequency of 112 kHz with a strength of 
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magnetic field of 250 Oe, viability was remained >90% for NIH3T3 cells, but the viability of 
K1735 cells was decreased to 24%, according to the results from MTT assay reported by K. S. 
Kim et al. [23]. 
 
   Using melanoma-tumor bearing mice, tumor-accumulation efficacy of AHP@MNPs was 
evaluated by the fluorescent intensity of tumor derived from PheoA. After 6 h from the 
intravenous injection of AHP@MNPs, high fluorescent intensity was observed at tumor, which 
indicative of accumulation of AHP@MNPs to tumor. Furthermore, the red fruorescence (PheoA 
of AHP@MNPs) was observed just around the nucleus (colored blue) of tumor cells, which is 
suggestive of cellular uptake of AHP@MNPs. From these results (reported by K. S. Kim et al. 
[23]), high tumor accumulation and internalization efficacy of AHP@MNPs was demonstrated in 
vivo. 
 
   At the point, the tumors were exposed to He-Ne laser at 200 mW/cm2 for 500 s and AC 
magnetic field for 30 min. As a result, one third or a half of smaller tumor volume was observed 
at 14 days after magnetic hyperthermia combined with photodynamic therapy than the tumor 
volume with no NPs (just injection of PBS) or with just hyperthermia treatment after 14 days 
from the exposure treatment, according to the in vivo results reported by K. S. Kim et al. [23], 
which suggestive of the potential of practical use of magnetic hyperthermia combined with 
photodynamic therapy using AHP@MNPs. 
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3.4 Conclusion 
 
   Surface design of MNPs with considered the enhancement of cellular uptake and therapeutic 
effect with another therapy as well as controlled magnetic property showed high potential of 
practical use of MNPs in magnetic hyperthermia. 
 
   In section 3.2, the cellular uptake of MNPs was indicated to induce a slight cell damage, which 
was reflected as an increase in generation of reactive oxygen species as well as an inhibition of 
cell proliferation, and to cause a high degree of cell death at the raised temperatures. A significant 
decrease in cell viability observed in the presence of intracellular MNPs under AC magnetic field 
may be originated from the combined or synergistic effect of intracellular heating and cellular 
damage by MNPs. 
 
   In section 3.3, design of surface and magnetic property of MNPs for in vivo application was 
investigated. To obtain the targeting ability to cancer cells, hyaluronic acid was modified onto 
MNPs. Hyaluronic acid has an advantage of specific binding to hyaluronic-acid receptor (CD44) 
overexpressed on cancer cells. To increase in therapeutic effect, pheophorbide-a was modified 
onto MNPs as a photosensitizer. Because pheophorbide-a generates reactive oxugen species when 
exposed to the light, increase in therapeutic effect by magnetic hyperthermia combined with 
photodynamic therapy is expected. Considered to the applied condition of AC magnetic field, 
superparamagnetic MNPs were employed. As a result, the designed MNPs was accumulated 
specific to tumor in mice, and then tumor growth was inhibited by magnetic hyperthermia 
combined with photodynamic therapy [23]. 
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Chapter 4 
 
Synthesis of MFe2O4 nanoparticles and their effect on breast cancer cell 
death under alternating magnetic field 
 
 
4.1 Introduction 
 
   For the development of effective magnetic hyperthermia, design of magnetic nanoparticles as 
a heat generator is focused in this chapter, as a study leading to the future technology. To increase 
the therapeutic effect of magnetic hyperthermia, this chapter describes the increase in heating 
capacity of nanoparticles with controlled magnetic properties considering the occupation of the 
A- and B-sites by transition metal cations (M2+ and Fe3+) in spinel structure. Many recent 
researches reported that the substitution of Fe2+ with other metal ions (MFe2O4; M = Ni, Co, Mn) 
improves the magnetic property and heating efficacy [1-3]. Therefore in this chapter, synthesis of 
cobalt and magnesium ferrite (CoFe2O4 and MgFe2O4) nanoparticles and their effect on death in 
human breast cancer MCF-7 cells under alternating magnetic field were investigated. Breast 
cancer was used as a cancer cells because magnetic hyperthermia can, in principle, be easily 
applied to tumors located on/under the human skin. 
 
   First, CoFe2O4 was selected owing to its potential of having greater magnetic anisotropy than 
iron-oxide nanoparticles [2,4]. High coercivity is expected from their large magneto-crystalline 
anisotropy (K), which should produce sufficient heat to induce cancer cell death under alternating 
magnetic field. When single-domain state and ferromagnetic property, coercivity (Hc) is estimated 
by the Stoner-Wohlfarth model based theory [5,6]: 
 
                             𝐻𝐶 = 0.98 × 𝐾 𝑀𝑠⁄                              (1) 
 
According to ref [2], the magnetic anisotropy of bulk CoFe2O4 is one-order larger than that of 
Fe3O4, whereas the saturation magnetization (Ms) of CoFe2O4 is almost 90% of Fe3O4. From the 
equation (1) and the information mentioned above, Hc of CoFe2O4 is estimated to be 10 times 
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larger than Fe3O4. Considering the Ms value also, approximately 9 times of enhancement in 
hysteresis area for CoFe2O4, as compared to Fe3O4. Because it can be suggested that heating 
capacity including the temperature rise and the specific absorption rate (SAR) is approximately 
proportional to the hysteresis area [7], 9-times enhancement of heating capacity is expected for 
CoFe2O4 nanoparticles, as compared to Fe3O4 nanoparticles with a same diameter. CoFe2O4 
nanoparticles were reported to have a potential of larger hysteresis area among other spinel ferrite 
nanoparticles [5]. Additionally, the amount of energy converted into heat per unit time and mass 
has been reported to be greater for CoFe2O4 nanoparticles than for other spinel ferrites of the same 
size, such as iron oxide [2]. The CoFe2O4 nanoparticles also maintain excellent chemical stability 
[8]. Therefore, in this study, the synthesis of CoFe2O4 nanoparticles by applying the synthetic 
method developed for Fe3O4 nanoparticles on the basis of hydrolysis in an aqueous solution 
containing iron(II) and iron(III) salts, in which organic amine plays significant role as a base and 
also as a protective reagent, was investigated, and their effect on cell death was examined. 
 
   However, even if CoFe2O4 nanoparticles have higher heating capacity and excellent chemical 
stability, administration of CoFe2O4 nanoparticles to human body has also a risk because Co2+ 
ions eluted from CoFe2O4 nanoparticles are toxic. 
 
   Hence in the next section, as a candidate of nanoparticles with high safety and high heating 
efficacy, MgFe2O4 was selected. MgFe2O4 nanoparticles are composed of non-toxic elements, 
suggesting that they have greater biocompatibility as compared to other ferrite nanoparticles. 
Furthermore, MgFe2O4 nanoparticles have been receiving attention as a new heat source because 
of their frequency-dependence of heating efficiency. Around 300 kHz, which corresponds to the 
frequency generally used for magnetic hyperthermia, the temperature rise of MgFe2O4 powder 
was reported to be highest among other kinds of ferrite powder [9]. When estimated the heating 
capacity using the difference of ∆T reported in Ref. 9, 8-times enhancement of heating capacity 
is expected for MgFe2O4, as compared to Fe3O4. Also, the SAR of MgFe2O4 nanoparticles was 
reported to be 297 W/g under safe strength and frequency of magnetic field [10], while the value 
was 20-40 W/g for superparamagnetic Fe3O4 nanoparticles under the same magnetic-field 
condition [11]. Hence, there are many reports regarding the synthesis of MgFe2O4 nanoparticles 
as shown in Table 4.1. However, a limited number of studies of the influence of MgFe2O4 
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nanoparticles on cells have been reported; especially the cell mortality associated with cellular 
uptake of MgFe2O4 nanoparticles is yet to be clearly discussed. In this study, synthesis of 
MgFe2O4 nanoparticles and the effect of their cellular uptake on the death under alternating 
magnetic field in MCF-7 cells were investigated.  
 
 
Table 4.1 Magnetic behavior and particle size of MgFe2O4 synthesized in various methods 
Synthetic method 
Magnetization 
(emu∙g-1) 
Particle size 
(nm) 
Coercivity 
(Oe) 
Reference 
combustion 33.83 10 - 30 53 [12] 
co-precipitation 4 (at 1 kOe) - - [13] 
microemulsion 1 (at 100 Oe) 20 - [14] 
sol-gel 15.3 6 - [15] 
co-precipitation 5.8 6 - [15] 
combustion 31.56 40 182 [16] 
hydrothermal - 3 - [17] 
ultrasound assisted 
ball-milling 
54.8 20 
- 
[18] 
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4.2 CoFe2O4 nanoparticles 
 
4.2.1 Experimental 
 
Synthesis and characterization of nanoparticles 
 
A 50-mL aqueous solution containing 0.017 mol·L-1 cobalt(II) chloride (CoCl2·4H2O) and 
0.033 mol·L-1 iron(III) chloride (FeCl3·6H2O) was prepared, and a 50-mL aqueous solution 
containing 0.123 mol·L-1 spermine, or N,N'-bis(3-aminopropyl)butane-1,4-diamine (pH 12.1) was 
also prepared as a base. After the aqueous solution containing spermine was heated at 90°C, the 
cobalt(II) and iron(III) chloride aqueous solution was added slowly to the aqueous spermine 
solution, which was followed by stirring for 12 h at 90°C. Finally, a black powder was obtained 
after washing the precipitate with water and ethanol several times and drying in a desiccator at 
room temperature. Fe3O4 nanoparticles with a diameter of 10 nm were also synthesized with the 
same procedure described in chapter 2, using iron(II) chloride (FeCl2·4H2O) and iron(III) chloride 
at a molar ratio of 2:1, and spermine as a base.  
The shape and size of CoFe2O4 nanoparticles were observed by field-emission transmission 
electron microscopy (FE-TEM) with a Hitachi HF-2200 microscope (Tokyo, Japan) at 200 kV 
and their composition and elemental mapping were analyzed by energy dispersive X-ray (EDX) 
analysis in FE-TEM. The shape and size of Fe3O4 nanoparticles were observed by TEM with a 
JEOL JEM-1011 microscope (Tokyo, Japan) at 100 kV. The mean diameters of those products 
were calculated using a following equation after counting and measuring diameters (Dn) of one 
hundred nanoparticles in the TEM images. 
 
Mean diameter =
(𝐷1+𝐷2+𝐷3+⋯+𝐷100)
100
                                         (2) 
 
The crystal structure of the products was characterized by X-ray diffraction (XRD) patterns 
recorded using a SmartLab diffractometer (Rigaku, Tokyo, Japan) with Co K radiation (1.7890 
Å). The magnetic field dependence of the magnetization curves of samples was measured by an 
MPMS 3 or MPMS 7 superconducting quantum interference device (SQUID; Quantum Design, 
Ltd., San Diego, CA) at 300 K, in which the applied range was from −10 kOe to 10 kOe. The zeta 
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potential and hydrodynamic diameter of the specimens dispersed in water at around pH 7 were 
evaluated with an Otsuka Electronics ELS-8000 electrophoretic light-scattering 
spectrophotometer (Osaka, Japan). 
 
MCF-7 cell cultivation 
 
Human breast cancer MCF-7 cells were cultured in Eagle’s minimum essential medium 
(EMEM, Sigma-Aldrich, St. Louis, MO) with 10% fetal bovine serum (FBS, ThermoFisher 
Scientific, Waltham, MA), 5% L-glutamine (Invitrogen, Life Technologies, Grand Island, NY), 
1% MEM non-essential amino acid (Gibco, Life Technologies), and 1% antibiotic-antimycotic 
(Gibco) under culture conditions of 37°C and 5% CO2. 
 
Cytotoxicity and cellular uptake study 
 
   MCF-7 cells were seeded in a 6-well dish at a density of 5 × 105 cells per 3 mL of medium in 
each well. CoFe2O4 or Fe3O4 nanoparticles in amounts of 0, 200, 400, 600, or 800 μg were added 
to each well and then incubated at 37°C at 5% CO2 for 24 h. After removing excess nanoparticles 
by three washes with Dulbecco’s phosphate buffered saline (DPBS; Gibco) followed by 
centrifugation at 1200 rpm for 5 min, the cells were dispersed in 1 mL of DPBS with 6% FBS. 
We used a BD Cell Viability Kit (BD Biosciences, Becton, Dickinson and Co., Franklin Lakes, 
NJ) to discriminate live cells, dead cells, and nanoparticles: 2 L of 42 μM thiazole orange (TO) 
in dimethyl sulfoxide and 1 L of 4.3 mM propidium iodide (PI) in water were added to 1 mL of 
cells suspended in DPBS, and then analyzed with a BD FACSCanto II flow cytometer. Live cells 
are PI negative and TO positive, dead cells are both PI and TO positive, and nanoparticles are 
both PI and TO negative. 
   Cellular viability as well as cellular uptake of nanoparticles can be analyzed via flow 
cytometry because increased side scatter (SSC), which is indicative of intracellular complexity, 
can be measured when the laser light crosses the cell in the flow cytometer, as described in the 
chapter 2. Hence, the SSC intensity of a cell that has incorporated nanoparticles is greater than 
that of a cell that has not incorporated nanoparticles. In the present study, the cellular uptake of 
CoFe2O4 and Fe3O4 nanoparticles was measured based on SSC intensity. 
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   The amount of nanoparticles contained per cell was also evaluated for both CoFe2O4 and 
Fe3O4 nanoparticles as described in the chapter 2. Intracellular Fe was formed into a thiocyanate-
iron(III) complex by using HCl, trichloroacetic acid solution, H2O2, and potassium thiocyanate 
solution, followed by measurement of absorbance at 480 nm using a JASCO V-550 
spectrophotometer (JASCO International Co. Ltd., Tokyo, Japan). 
   To observe cellular uptake of nanoparticles with an optical microscope, prussian blue staining 
was performed using an Iron Stain Kit (Sigma-Aldrich), by which iron-containing nanoparticles 
turned blue and cells were stained red. Iron stain solution including potassium ferrocyanide 
solution and hydrochloric acid solution at a ratio of 1:1 was added to DPBS-washed cells at a 
particle dose of 200 μg in a 6-well dish. After 10 min, the residues were rinsed away with DPBS. 
Then, pararosaniline solution was added for staining cells, and after 5 min, the residues were 
rinsed away with DPBS. The cells were then observed under a Nikon TE2000-U microscope 
(Tokyo, Japan). 
 
Evaluation of the dissolution of Co2+ from CoFe2O4 nanoparticles in water 
 
CoFe2O4 nanoparticles (1 mg) were dispersed in 3 mL of water in a polypropylene tube 
(around pH 7). After a 24-h or 72-h incubation at 37°C and 5% CO2, the supernatants of both 
samples were collected by centrifugation, and the concentration of Co2+ in the sample was 
measured by a Thermo Scientific iCAP Qc inductively coupled plasma-mass spectrometer (ICP-
MS). Before measurements, a calibration curve of Co2+ concentration was made using a cobalt 
standard solution (Co in 0.1 mol/L HNO3; Kanto Chemical Co. Ltd., Tokyo, Japan). The 
concentration of Co2+ in the samples was calculated using the calibration curve. 
 
Evaluation of cell death with nanoparticles under alternating magnetic field 
 
   To test cell viability, 5 × 105 MCF-7 cells were cultured per well in the presence of CoFe2O4 
or Fe3O4 nanoparticles (0, 200, 400, 600, or 800 μg per well). After washing the cells three times 
with DPBS, the cells containing nanoparticles were collected by magnetic separation and 
suspended in 500 μL of medium. An AC magnetic field was applied for 20 min using both a 3-
turn coil with an outer diameter of 40 mm and an EASYHEAT induction-heating device (Alonics, 
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Ltd., Tokyo, Japan) operated at an output power of 4.3 kW, an electric current of 569.1 A, and a 
frequency of 325 kHz, from which the strength of the magnetic field was calculated to be 536 Oe. 
The change in temperature under the AC magnetic field was monitored with an Anritsu FL-2000 
fiber thermometer (Tokyo, Japan). Temperature curves were also obtained for 500 μL of water 
containing 1 mg of nanoparticles without cells. Cell death mediated by nanoparticles subjected to 
the AC magnetic field was analyzed by flow cytometry using PI and TO staining. 
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4.2.2 Characterization of nanoparticles 
 
   First of all, establishment of synthetic method for single-domain CoFe2O4 nanoparticles with 
high crystalline was discussed. When synthesized by directly applied the synthetic method 
developed for Fe3O4 nanoparticles as described in chapter 1.2.4 and 2.2 except for using Co2+ 
instead of Fe2+, the products did not have magnetism. This could be because Co2+ is difficult to 
occupy B-site than Fe2+ in the inverse spinel structure. Then, to active the Co2+ behavior, the 
prepared solution was heated to 90°C. As a result, single-domain CoFe2O4 nanoparticles with 
high crystalline and high magnetism were obtained. From this experience, heating was suggested 
to be useful approach to form MFe2O4 with high crystalline. 
 
Fig. 4.1A and 4.1B depict the TEM images of CoFe2O4 and Fe3O4 nanoparticles, respectively, 
and revealed that both particles were spherical or truncated cubic in shape, with a mean diameter 
of 9.4 ± 2.4 for CoFe2O4 and 11.1 ± 2.5 nm for Fe3O4. The mean diameter of CoFe2O4 
nanoparticles was calculated from randomly collected 100 particles in its TEM image. Size 
distribution of CoFe2O4 nanoparticles is shown in Fig. 4.2. For CoFe2O4 nanoparticles, the ratio 
of Co to Fe in an individual particle was analyzed by EDX. It is known that ICP shows a higher 
precision and lower detection limit than EDX. However, EDX can provide the composition with 
certain accuracy although that depends on the element to be analyzed. Indeed EDX has been 
frequently used to determine the chemical composition of materials, for example electrodeposited 
thin films containing Co and Fe such as alloy films and nanoparticles consisting of Co and Fe. 
Hence EDX have been chosen in order to discuss not the mean composition of products but the 
difference in localized areas or in particle-by-particle. The ratio of oxygen could not be precisely 
determined due to the limitations of the measurement method. The EDX results suggest that the 
atomic ratio of Co to Fe is 1 to 2, and particles composed of only cobalt or iron were not observed. 
To discuss the composition of products, the elemental mapping of CoFe2O4 nanoparticles was 
also examined as shown in Fig. 4.3. Fe and Co were found to exist uniformly along nanoparticles 
with the Co:Fe atomic ratio of 1:2. Fig. 4.3C shows XRD patterns for the products synthesized 
with cobalt(II) chloride and iron(III) chloride (a) and with iron(II) chloride and iron(III) chloride 
(b). The pattern (a) was matched with the standard pattern of CoFe2O4 (JCPDS# 22-1086) and the 
pattern (b) was matched with the standard pattern of Fe3O4 (JCPDS# 19-0629). Although both 
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patterns resembled each other, the positions of diffractions peaks were slightly but certainly 
different between the patterns (a) and (b). For example, the d values of the lattice spacing of (311) 
was calculated to be 2.526 Å for pattern (a) and 2.529 Å for pattern (b) by using the Bragg 
equation for the peak observed at 2θ ~ 41°, and the slight difference in these values was 
attributable to the difference between theoretical values of 2.531 Å for CoFe2O4 (JCPDS# 22-
1086) and 2.532 Å for Fe3O4 (JCPDS# 19-0629). The crystallite size calculated from XRD by 
applying Scherrer’s formula to the (311) diffraction peak was 8 nm (in diameter) for the both 
patterns (a) and (b), which is consistent with the TEM results. Thus, products (a) and (b) were 
identified to be CoFe2O4 and Fe3O4, respectively, with a spinel structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.1 Characterization of CoFe2O4 and Fe3O4 nanoparticles employed in this study. TEM 
images of CoFe2O4 nanoparticles (A) and Fe3O4 nanoparticles (B), and XRD patterns with Co K 
radiation (C): CoFe2O4 (a) and Fe3O4 (b). Reprinted with permission. Copyright @ 2015 Elsevier 
B. V. 
A B
50 nm 50 nm
C
20 35 50 65 80 95 110
In
te
n
s
it
y
2
2
0
2
2
0
3
1
1
3
1
1
4
0
0
5
1
1
4
4
0
4
0
0
5
1
1 4
4
0
(a)
(b)
2q / degree
 82 
 
Chapter 4 
 
 
 
 
 
 
 
 
 
Fig. 4.2 Size distribution of synthesized CoFe2O4 nanoparticles. 
 
 
 
 
 
 
 
Fig. 4.3 Elemental mapping of the synthesized nanoparticles: the image of nanoparticles (a), Fe 
mapping (b), and Co mapping (c). Reprinted with permission. Copyright @ 2015 Elsevier B. V. 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4 Size distribution of CoFe2O4 and Fe3O4 nanoparticles in water characterized by dynamic 
light scattering. 
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The results of TEM, EDX analysis, elemental mapping, and XRD measurements suggest that 
CoFe2O4 nanoparticles with a diameter of 10 nm were synthesized without composites of Co3O4, 
Fe3O4, and -Fe2O3. The formation of CoFe2O4 likely progressed by a generally known co-
precipitation reaction represented by the following equation [19]: 
 
Co2+ + 2Fe3+ + 8OH− → CoFe2O4 + 4H2O.                                     (3) 
 
   The size distribution in water was characterized by dynamic light scattering for the 
nanoparticles synthesized in this study. As shown in Fig. 4.4, both nanoparticles were stable in 
water with forming secondary particles with hydrodynamic diameters of approximately 200 nm 
or 1 m, similar to the study for Fe3O4 nanoparticles described in chapter 2. 
   Fig. 4.5 shows the magnetization curves of CoFe2O4 and Fe3O4 nanoparticles at 300 K. As 
depicted in Fig. 4.5, the magnetization value at the 10000 Oe field of both CoFe2O4 and Fe3O4 
nanoparticles was found to be 60 emu·g-1. The magnetization values observed for the synthesized 
nanoparticles with a diameter of 10 nm were slightly smaller than those of bulk materials, which 
could be due to the effect of increased thermal fluctuation near the surface of nanoparticles or that 
of the magnetically disordered surface formed because of the large surface-to-volume ratio [20]. 
As also shown in Fig. 4.5, the coercivity of CoFe2O4 was 200 Oe and that of Fe3O4 was less than 
10 Oe, suggesting that CoFe2O4 nanoparticles show a ferromagnetic type of behavior, whereas 
Fe3O4 demonstrate superparamagnetic behavior. Hence, the heat derived from CoFe2O4 is 
generated by hysteresis loss, and the heat generated by Fe3O4 is largely controlled by Néel and 
Brown relaxation under the AC magnetic field [2,21-23]. Thus, the substitution of Fe2+ with Co2+ 
is likely to result in an increase in coercivity. 
Fig. 4.6 shows the temperature curve measured for 500 L of water containing 1 mg of 
nanoparticles without cells under an AC magnetic field (569.1 A, 325 kHz) for 20 min using a 3-
turn coil with an outer diameter of 40 mm (the strength of magnetic field was theoretically 
calculated to be 536 Oe). The temperature of CoFe2O4 nanoparticles was higher than that of Fe3O4, 
whose average temperature measured between 400 and 1200 s was 56°C for CoFe2O4 and 45°C 
for Fe3O4. From the initial slope of these time-dependent temperature curves in the first 100 s, 
specific absorption rates (SARs) of 404 and 319 W·g-1 was obtained for CoFe2O4 and Fe3O4 
nanoparticles, respectively, under this condition by the following equation: 
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SAR =
𝛴𝑖 𝐶𝑝𝑖 𝑚𝑖
𝑚𝑁𝑃𝑠
∙
∆𝑇
∆𝑡
                                                       (4) 
 
where Cpi and mi are specific heat capacity and mass for each substance, and mNPs is the mass of 
nanoparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.5 Magnetization curves of CoFe2O4 and Fe3O4 nanoparticles. The curves were measured 
by SQUID at 300 K between −10000 and 10000 Oe of magnetic field strength. Reprinted with 
permission. Copyright @ 2015 Elsevier B. V. 
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Fig. 4.6 Time dependence of the temperature curve of 1 mg of CoFe2O4 or Fe3O4 nanoparticles in 
500 L of water under an AC magnetic field. Reprinted with permission. Copyright @ 2015 
Elsevier B. V. 
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4.2.3 Evaluation of cellular uptake and cell death 
 
   Next, the influence of nanoparticles on human breast cancer MCF-7 cells was investigated. 
Fig. 4.7 shows the percentage of cells containing nanoparticles (A) and the percentage of non-
viable cells (B). As depicted in Fig. 4.7A, the percentage of cells containing nanoparticles tended 
to increase at the higher doses of both types of particles: at 200 g, the percentage of cells 
containing nanoparticles was 50−60% and at 800 g, the percentage of cells containing 
nanoparticles was 80%. No more than 10% cell mortality was observed following 24-h incubation 
with nanoparticles at concentrations from 0 to 800 g. Neither Fe3O4 nor CoFe2O4 nanoparticles 
killed MCF-7 cells despite cellular uptake. Although the percentage of MCF-7 cell death observed 
with CoFe2O4 nanoparticles seems slightly higher than that for Fe3O4 at all doses, it should be 
noted that this tendency was observed even in the control experiment (without nanoparticles); the 
cell mortality was constant at the dose range from 0 to 800 μg for both Fe3O4 and CoFe2O4 
nanoparticles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.7 Dependence of the percentage of cells containing nanoparticles (A) and the percentage 
of non-viable cells (B) on the amount of CoFe2O4 (circles) or Fe3O4 (triangles) nanoparticles 
added to 5 × 105 MCF-7 cells. Reprinted with permission. Copyright @ 2015 Elsevier B. V. 
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   However, CoFe2O4 nanoparticles might derive cytotoxicity from Co2+ [24,25] eluted from 
CoFe2O4. For example, Catelas et al. [24] reported that Co2+ induces apoptosis via a caspase-3 
pathway. To consider the influence of dissolved Co2+, we examined Co2+ elution by ICP-MS under 
almost identical conditions as those used for the cytotoxicity test: the concentration was 1 mg of 
CoFe2O4 nanoparticles per 3 mL of H2O at 37°C. As shown in Table 4.2, few Co2+ were eluted 
into the water from CoFe2O4 nanoparticles: the concentration of Co2+ in the sample was 0.785 
μg·mL-1 (0.9% of Co was eluted) after a 24-h incubation, and 0.465 μg·mL-1 (0.6% of Co was 
eluted) after a 72-h incubation. The decrease of Co2+ concentration from 24 h to 72 h seems to be 
related to the adsorption of Co2+ to the surface of the polypropylene tube. Indeed, Kwon et al. 
[25] investigated the cytotoxicity of Co ions released from Co nanoparticles on RAW263.7 
macrophage cells in vitro, and reported that Co ions at a concentration of 0.630 μg·mL-1 show no 
cytotoxic effect, but 4.777 μg·mL-1 of Co ions was cytotoxic. Based on this information, we 
conclude that an extensive elution of Co2+ from CoFe2O4 nanoparticles was not observed in this 
case, but further surface modification of CoFe2O4 should be the key when their practical 
application to magnetic hyperthermia is considered. 
 
 
Table 4.2 Co2+ elution at the concentration of 1 mg of CoFe2O4 nanoparticles per 3 mL of H2O. 
Reprinted with permission. Copyright @ 2015 Elsevier B. V. 
 Concentration / g·mL-1 Elution percentage (%) 
Water 0.00004 0.0 
24 h 0.785 0.9 
72 h 0.465 0.6 
 
 
   Fig. 4.8 shows the dose dependence of the uptake of CoFe2O4 and Fe3O4 nanoparticles by 
MCF-7 cells. The CoFe2O4 nanoparticles were incorporated at a lower concentration than Fe3O4 
nanoparticles. Approximately 75 pg of both types of nanoparticles was incorporated into each cell 
at a dose of 200 μg per 5 × 105 cells, and 200 pg (for CoFe2O4) or 230 pg (for Fe3O4) of 
nanoparticles was incorporated per cell at the dose of 800 μg. Based on the previous finding [26], 
this slight difference in uptake could be induced less by the composition of the nanoparticles than 
by their zeta potential. The zeta potential in water at around pH 7 was +2.6 mV for CoFe2O4 
 88 
 
Chapter 4 
nanoparticles and +9.3 mV for Fe3O4 nanoparticles. The positive value of the zeta potential at pH 
7 is attributable to the cationic form of amine groups in spermine adsorbed on the surface of 
nanoparticles [26]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.8 Dependence of the amount of incorporated nanoparticles per cell on the amount of 
CoFe2O4 (circles) or Fe3O4 (triangles) nanoparticles added to 5 × 105 MCF-7 cells. Reprinted with 
permission. Copyright @ 2015 Elsevier B. V. 
 
 
   The uptake of nanoparticles into MCF-7 cells was observed with an optical microscope at the 
dose of 200 μg. In Fig. 4.9, MCF-7 cells were stained red and nanoparticles were stained blue by 
iron stain. Compared with the image of MCF-7 cells without the dose of nanoparticles (Fig. 4.9A), 
the incorporation of nanoparticles did not alter the apparent morphology of cells for both CoFe2O4 
(Fig. 4.9B) and Fe3O4 (Fig. 4.9C). The nanoparticles were observed within the cytoplasm but not 
in the nucleus. The ratio of cells containing nanoparticles observed in those optical microscopic 
images was comparable to that evaluated by flow cytometry (Fig. 4.7). In addition, the amount of 
incorporated nanoparticles appeared to be similar for both CoFe2O4 and Fe3O4 nanoparticles, 
which is consistent with the result shown in Fig. 4.8. Therefore, cellular uptake of nanoparticles 
was evidenced by the results shown in Figs. 4.7, 4.8, and 4.9. 
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Fig. 4.9 Optical microscopic images of MCF-7 cells without nanoparticles (A), those containing 
CoFe2O4 nanoparticles (B), and those containing Fe3O4 nanoparticles (C). In these images, cells 
were stained red whereas nanoparticles were stained blue by iron stain. Reprinted with permission. 
Copyright @ 2015 Elsevier B. V. 
 
 
   To determine the potential of 10-nm CoFe2O4 nanoparticles for efficiently inducing cancer 
cell death, MCF-7 cells with incorporated nanoparticles were subjected to alternating magnetic 
field (using a 3-turn coil with an outer diameter of 40 mm at 325 kHz and 569.1 A) for 20 min, 
of which strength was calculated to be 536 Oe. Based on the temperature curves measured for 
nanoparticles under the AC magnetic field (Fig. 4.10), the temperature of CoFe2O4 nanoparticles 
was greater than that of the Fe3O4 nanoparticles incubated at the same dose, suggesting that 
CoFe2O4 nanoparticles convert the magnetic field into heat more efficiently than did Fe3O4 
nanoparticles under this condition. Considering the magnetic properties of the nanoparticles (Fig. 
4.5) and the amount taken up by the cells (Fig. 4.8), the greater temperature reached by CoFe2O4 
nanoparticles is strongly expected to be attributable to their coercivity, even though the amount 
of CoFe2O4 nanoparticles incorporated into a cell was smaller than that of the Fe3O4 nanoparticles. 
Following exposure to the AC magnetic field, the percentage of non-viable MCF-7 cells incubated 
with every dose of nanoparticles was evaluated by flow cytometry. As shown in Fig. 4.11, 53% 
cell death could be induced using CoFe2O4 nanoparticles and the AC magnetic field. On the other 
hand, Fe3O4 nanoparticles did not significantly induce cell death as only 17% of non-viable cells 
was observed even at the 800 μg dose of nanoparticles. Based on the temperature shown in Fig. 
4.11 which is the average temperature measured between 400 and 1200 s in Fig. 4.10, the higher 
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temperature induced greater cell mortality, which was especially significant when the temperature 
reached 43°C (critical temperature for cell death). Thus, under the tested conditions, the heat 
generated by 10-nm CoFe2O4 nanoparticles under an AC magnetic field was found to be sufficient 
for human breast cancer cell death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.10 Time dependence of the temperature change in MCF-7 cells containing CoFe2O4 (a) or 
Fe3O4 (b) nanoparticles under an AC magnetic field (325 kHz, 500 Oe). Control cells were not 
treated with nanoparticles. The inserted 200, 400, 600, and 800 μg indicate the amount of 
nanoparticles added to 5 × 105 MCF-7 cells, not the amount of incorporated nanoparticles. 
Reprinted with permission. Copyright @ 2015 Elsevier B. V. 
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Fig. 4.11 Dependence of the percentage of non-viable MCF-7 cells containing CoFe2O4 (a) or 
Fe3O4 (b) nanoparticles soon after exposure to AC magnetic field (ACMF; 325 kHz, 500 Oe) for 
20 min on the amount of nanoparticles added to 5 × 105 cells. The temperatures indicated are the 
average temperatures between 400 and 1200 s in Fig. 4.10. Reprinted with permission. Copyright 
@ 2015 Elsevier B. V. 
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4.3 MgFe2O4 nanoparticles 
 
4.3.1 Experimental 
 
Synthesis and characterization of nanoparticles 
 
   MgFe2O4 nanoparticles were synthesized with two steps. In the first step, 24 mL of an aqueous 
solution containing 0.4 mmol of magnesium chloride (MgCl2∙6H2O) and 0.8 mmol of iron 
chloride (FeCl3∙6H2O) was added slowly into a 0.246 M aqueous sodium hydroxide (NaOH) 
solution (pH 12.4) as a base at room temperature, followed by stirring for 4 h and washing the 
brown precipitate with water and ethanol. In the second step, the resultant brown powder was 
annealed at 800°C for 10 min in air with the rate of temperature rise/drop of 20/6 °C∙min-1 
(MFNPs1) or 260/140 °C∙min-1 (MFNPs2) using an electronic furnance TMF-2200 (Tokyo 
Rikakikai Co. Ltd., Tokyo, Japan).  
FeCl3∙6H2O was purchased from Kanto Chemical Co. Ltd., Tokyo, Japan, MgCl2∙6H2O and 
NaOH were purchased from Wako Pure Chemical Industries, Ltd., Osaka, Japan.  
   Characterization of MgFe2O4 nanoparticles was performed with the same method and 
procedure described in the previous section 4.2.1, except for using Agilent 5100 ICP-OES 
(Agilent Technologies, Tokyo, Japan) instead of EDX for the composition analysis of MgFe2O4 
nanoparticles. The mean diameter of nanoparticles was calculated using a equation (2) after 
counting and measuring diameters (Dn) of fifty nanoparticles in the TEM images. 
 
 
In vitro evaluation using MCF-7 cells 
 
   Cell culture, cytotoxicity and cellular uptake study, and evaluation of cell death under AC 
magnetic field were performed with the same method and procedure described in the previous 
section 4.2.1, except for the dose amount. In this study, MgFe2O4 nanoparticles in amounts of 0, 
1, 5 mg were added to 5 × 105 MCF-7 cells. 
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4.3.2 Characterization of nanoparticles 
 
   First of all, establishment of synthetic method for single-domain MgFe2O4 nanoparticles with 
high crystalline and high magnetism was discussed. When synthesized by directly applied the 
synthetic method developed for Fe3O4 nanoparticles as described in chapter 1.2.4 and 2.2 except 
for using Mg2+ instead of Fe2+, the products was suggested to be a mixture of Fe(OH)3, Mg(OH)2, 
and MgFe2O4 with a very small particle size because its XRD pattern showed broad peaks. 
According to the reports of the synthesis of MgFe2O4 [12-18], high-temperature treatment is 
needed to form MgFe2O4. Hence, to react Fe(OH)3 with Mg(OH)2 (form MgFe2O4), annealing 
process was added. In the annealing process, spermine (reactive reagent) was suggested to disrupt 
the reaction of Fe(OH)3 and Mg(OH)2, NaOH was employed as a base in the co-precipitation 
method. Annealing temperature and time is also important to obtain the single-domain 
nanoparticles with high crystalline and without sintering. As a result, 800°C of annealing 
temperature and 10 min of annealing time were employed in this study. 
   
 
   Fig. 4.12 shows XRD patterns for the products after annealing (MFNPs1 and MFNPs2). The 
peaks of both particles represent spinel structure and correspond well with the standard pattern of 
MgFe2O4 (Cambridge Structural Database (CSD) 9003790). The d value of the lattice spacing of 
(311) was calculated to be 2.531 Å for both samples by using the Bragg equation for the peak 
observed at 2θ ~ 41°, which were similar to the value of commercial MgFe2O4 (2.526 Å). The 
formation of Fe3O4 or -Fe2O3 is unlikely as they transform to -Fe2O3 with a corundum structure 
at 500°C [27]. Although the presence of tiny amount of MgO was suggested for both sample as 
the MgO was reported to form with the oxidation of Mg(OH)2 at 400°C [28], the formation of 
MgO seemed smaller for MFNPs2 than for MFNPs1. The formation of MgO is unfavorable but 
it is not impossible from the aspect of ∆G [29], which suggests that its amount depends on the 
annealing time. The crystallite size calculated from XRD by applying Scherrer’s formula to the 
(311) diffraction peak was 37 or 39 nm for MFNPs1 or MFNPs2. The composition analysis was 
investigated by ICP, which indicated the Mg:Fe atomic ratio of 1:2 for both samples. 
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Fig. 4.12 XRD patterns with Co K radiation: MFNPs1, MFNPs2, and CSD# 9003790. 
 
   Fig. 4.13 shows TEM images of MFNPs1 and MFNPs2, and revealed that both particles were 
assembled with a shape of spherical or truncated cubic. Fifty nanoparticles were counted to 
determine their size distribution; the mean particle diameters were 37.0 ± 12.6 nm and 40.8 ± 12.4 
nm, shown in Fig. 4.14, respectively. These diameters corresponded to crystallite size calculated 
from XRD by a Scherrer’s formula.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.13 TEM images of MFNPs1 (A,C) and MFNPs2 (B,D). Scale bar: 50 nm (A,B), 200 nm 
(C,D). 
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Fig. 4.14 Size distribution of MFNPs1 and MFNPs2. 
 
 
   The size distribution in water was characterized by dynamic light scattering for MFNPs1 and 
MFNPs2. As shown in Fig. 4.15, MFNPs1 and MFNPs2 were stable in water with forming 
secondary particles with hydrodynamic diameters of approximately 1000 nm and 100 nm, 
respectively. Because the zeta potential measured in water at pH 5.8 was -12.6 mV and -6.6 mV 
for MFNPs1 and MFNPs2, the difference of their dispersity is derived from other interaction 
forces (not electrostatic repulsive interaction). It is well known that sintering occurs when 
annealing of particles at high temperature. For MFNPs2, which is annealed with the rapid rate of 
heating/cooling, the holding time at high temperature is shorter than MFNPs1, suggesting the 
possibility of the sintering reduction. Hence, this difference of sintering degree may influence the 
dispersity of MgFe2O4 nanoparticles.  
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Fig. 4.15 Size distribution of MgFe2O4 nanoparticles in water characterized by dynamic light 
scattering. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.16 Magnetization curves of MgFe2O4 nanoparticles. The curves were measured by SQUID 
at 300 K between -70 kOe and 70 kOe of magnetic field. Curves (B) are extracted from the curves 
(A) in an applied field range between -500 Oe and 500 Oe. 
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   Fig. 4.16 shows the magnetization curves of MFNPs1 and MFNPs2 at 300 K. As depicted in 
Fig. 4.16A, the magnetization values at 70 kOe of MFNPs1 and MFNPs2 were found to be 33 
and 37 emu/g respectively, which indicated that the rapid rate of heating/cooling increases the 
saturation magnetization value of MgFe2O4 nanoparticles due to two supposable reasons. One is 
the smaller formation of MgO, the other is the increase in the ratio of Mg2+ occupied in the A site 
of spinel structure induced by rapid cooling [30]. Fig. 4.16B is extracted from Fig. 4.16A in an 
applied field range between -500 Oe and 500 Oe. MFNPs1 and MFNPs2 showed a ferromagnetic 
behavior with a coercivity of 50 Oe and 60 Oe, respectively. This difference could be influenced 
by the sintering degree as mentioned above. Overall, the hysteresis area between -500 and 500 
Oe for MFNPs2 was approximately 1.5 times greater than that for MFNPs1, as calculated using 
an Image J software [31]. 
 
   Fig. 4.17 shows the temperature curve measured for 500 μL of water containing 1 mg of 
nanoparticles without cells under AC magnetic field (569.1 A, 325 kHz) for 20 min using a 3-turn 
coil with an outer diameter of 40 mm (the strength of magnetic field was theoretically calculated 
to be 536 Oe). The temperature of MFNPs2 was higher than MFNPs1, whose average temperature 
measured between 800 and 1200 s was 39°C and 45°C for MFNPs1 and MFNPs2. From the initial 
slope of these time-dependent temperature curves in the first 100 s, SARs of 208 and 310 W·g-1 
was obtained for MFNPs1 and MFNPs2, respectively. The ∆T and SAR of MFNPs2 was about 
1.5 times higher than those of MFNPs1, which corresponded the degree of hysteresis-area 
enhancement as described above. 
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Fig. 4.17 Time dependence of the temperature curve of 1 mg of MgFe2O4 nanoparticles in 500 
L of water under AC magnetic field (325 kHz, 500 Oe). 
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4.3.3 Evaluation of cellular uptake and cell death 
 
   Using MFNPs2, the influence of nanoparticles on human breast cancer MCF-7 cells. Fig. 4.18 
shows the percentage of cells containing nanoparticles (A) and the percentage of non-viable cells 
(B). As depicted in Fig. 4.18A, the percentage of cells containing nanoparticles tended to increase 
at the higher doses of both types of particles: 40% of cells incubated with 1 mg reaching 95% of 
cells incubated with 5 mg. No more than 10% cell mortality was observed following the addition 
of nanoparticles even at the concentration of 5 mg per 3 mL of medium. For Fe3O4 nanoparticles, 
murine macrophage (J774) cells were induced cell death following incubation with 500 g/mL of 
Fe3O4 nanoparticles [32]. Therefore, high biocompatibility of MgFe2O4 nanoparticles was 
suggested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.18 Dependence of the percentage of cells containing nanoparticles (A) and the percentage 
of non-viable cells (B) on the amount of MgFe2O4 nanoparticles added to 5 × 105 MCF-7 cells. 
 
 
   Fig. 4.19 shows the dose-dependence of the uptake of MgFe2O4 nanoparticles by MCF-7 cells. 
Approximately 1 ng of MFNPs2 was incorporated into a cell at a dose of 1 mg per 5 × 105 cells, 
and 3 ng of nanoparticles was incorporated per cell at the dose of 5 mg. Compared with other 
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ferrite nanoparticles, the amount of incorporated nanoparticles for MgFe2O4 seems to be larger in 
the range showing high viability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.19 Dependence of the amount of incorporated nanoparticles per cell on the amount of 
MgFe2O4 nanoparticles added to 5 × 105 MCF-7 cells. 
 
 
   To determine the potential of MgFe2O4 nanoparticles for use in magnetic hyperthermia, MCF-
7 cells with internalized nanoparticles were subjected to AC magnetic field (325 kHz, 500 Oe) 
for 20 min. As shown in Fig. 4.20, 90% of cell death could be induced using MgFe2O4 
nanoparticles with a dose of 5 mg and the AC magnetic field. On the other hand, 1 mg of MgFe2O4 
nanoparticles did not significantly induce cell death as 10% of non-viable cells were observed. 
Based temperature in shown in Fig. 4.20, which is the average temperature measured between 
800 and 1200 s in the temperature curves, the higher temperature induced greater cell mortality 
which was especially significant when the temperature reached >43°C (critical point of cell death). 
Thus, under the tested conditions, the heat generated by 40 nm MgFe2O4 nanoparticles annealed 
with the rapid rate of heating/cooling under AC magnetic field was found to be sufficient for 
cancer cell death. 
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Fig. 4.20 Dependence of the percentage of MCF-7 cells containing MgFe2O4 nanoparticles soon 
after 20-min exposure to AC magnetic field (325 kHz, 500 Oe) on the amount of nanoparticles 
added to 5 × 105 cells. The inserted temperatures are the average temperatures between 800 and 
1200 s of samples under AC magnetic field. 
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4.4 Comparison of heating capacity of MFe2O4 nanoparticles 
 
   The summary of the characteristics of MFe2O4 nanoparticles employed in this thesis is shown 
in Table 4.3. The AC magnetic field, with a strength of magneticfield of 536 Oe with a frequency 
of 325 kHz, was applied in this thesis. The concentration of nanoparticles under AC magnetic 
field was 1 mg of particles dispersed in 500 L of water. 
 
 
Table 4.3 Summary of the characteristics of MFe2O4 nanoparticles employed in this thesis. 
 
 
 
 
 
 
 
 
*Reached temperature was shown as the average temperature between 400-800 s for 10-nm Fe3O4 
and 9-nm CoFe2O4, 800-1200 s for 43 nm Fe3O4 and 39-nm MgFe2O4 of their temperature curves 
under AC magnetic field. 
 
 
   From Table 4.3, it was understood that larger hysteresis area induced higher reached 
temperature and higher SAR. Hence, although it is difficult to estimate of heating amount exactly 
because it is affected by the treated environmental conditions etc., the most important 
characteristics for effective magnetic hyperthermia is suggested to have larger magnetization and 
larger coercivity in the range of applied magnetic field. This is the reason for showing the highest 
heating efficacy of 40-nm Fe3O4 nanoparticles. However in fact, it was found by in vitro 
evaluation of the interaction of particles and cells that other factors should be also considered. For 
example, considering to cellular uptake amount and percentage of cells containing nanoparticles, 
MgFe2O4 may be more favorable as shown in section 4.3 related to their high biocompatibility. 
CoFe2O4 MgFe2O4
Size 10 nm 43 nm 9 nm 41 nm
Magnetization
(at 10 kOe)
~60 emu/g ~90 emu/g ~60 emu/g
37 emu/g
(at 70 kOe)
Coercivity < 10 Oe ~200 Oe ~200 Oe ~60 Oe
Reached
temperature
45°C 63°C 56°C 45°C
SAR (at 100 s) 319 W/g 792 W/g 404 W/g 310 W/g
Fe3O4
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On the other hand, there is a concern of toxicity in CoFe2O4 nanoparticles although showing the 
higher heating efficacy than the same diameter of Fe3O4 nanoparticles. <10-nm sized 
nanoparticles have an advantage of “stealth” effect for phagocytosis by macrophage stayed in the 
human body. 
   As mentioned above, determining the most feasible ferrite nanoparticles is difficult due to the 
involvement of many factors for effective hyperthermia. However, the control of the occupation 
of the A- and B-sites by transition metal cations (M2+ and Fe3+) in spinel structure is suggested to 
be significant as a future technology to achieve more effective magnetic hyperthermia 
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4.5 Conclusion 
 
   In this chapter, magnetic property of ferrite nanoparticles was controlled in order to increase 
their heating efficiency and induce cell death effectively under AC magnetic field.  
 
First, synthesis and in vitro evaluation of CoFe2O4 nanoparticles were described. Because they 
have larger magneto-crystalline anisotropy than Fe3O4 nanoparticles, high heating efficacy 
derived from high coercivity is expected under AC magnetic field. As a consequence, CoFe2O4 
nanoparticles synthesized exhibit greater coercivity than Fe3O4 nanoparticles with almost the 
same diameter. An enhancement of hysteresis area derived from increase in the coercivity was 
confirmed to cause a higher heating efficiency of nanoparticles under an AC magnetic field. It 
was also demonstrated that cell death attributable to heat not to cytotoxicity was observed rapidly 
following exposure to AC magnetic field in MCF-7 cells containing CoFe2O4 nanoparticles with 
a diameter of 10 nm, whereas MCF-7 cell death was not induced using 10-nm MNPs under the 
same conditions.  
 
Second, from the aspect of frequency-dependence of heating efficiency, synthesis and in vitro 
evaluation of MgFe2O4 nanoparticles were described. Around 300 kHz, which corresponds to the 
frequency generally used for magnetic hyperthermia, the temperature rise of MgFe2O4 powder 
was literature-reported to be highest among other kinds of ferrite powder. As a result, 40-nm 
MgFe2O4 nanoparticles with a ferromagnetic property were obtained. Then, MCF-7 cells 
internalized large amount of MgFe2O4 nanoparticles, and the temperature rise and 90% of cell 
mortality was observed when subjected to AC magnetic field, with high biocompatibility. 
 
These results will assist in the design of magnetic nanoparticles as heat elements for magnetic 
hyperthermia, although further investigation including surface modifications of prevent Co2+ 
elution or improvement of magnetic property of MgFe2O4 will be necessary. Furthermore, 
increase in magnetization value of ferrite nanoparticles is also considered to be an effective 
approach as a method of enhancement of hysteresis area. MnFe2O4 and Mn0.5Zn0.5Fe2O4 are 
candidate to show higher magnetization than Fe3O4 nanoparticles from the aspect of amount of 
magnetic moment. In this situation, considering to biocompatibility of nanoparticles, a study of 
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Cu0.5Zn0.5Fe2O4 nanoparticles is now in progress because their saturation magnetization value 
estimated is also expected to be higher than other ferrite nanoparticles such as Fe3O4, CoFe2O4, 
and MgFe2O4. 
 
   Controlling magnetic properties of ferrite nanoparticles appropriate to application types is 
suggested to be important because the remarkable advantage is different among the kinds of ferrite 
nanoparticles. For increase in heating capacity, the strategy of enhancement of hysteresis area of 
nanoparticles is feasible. However, there may be a concern that the death of normal cells are also 
induced even when they internalized a little amount of nanoparticles having a large hysteresis 
area such as CoFe2O4. Using nanoparticles with a moderate hysteresis area such as MgFe2O4, mild 
hyperthermia can be achieved. Taking advantage of higher coercivity of CoFe2O4 nanoparticles, 
effective cell separation is expected. On the other hand, taking advantage of larger amount of 
internalization with an excellent biocompatibility, effective biotechnology such as internalization 
of vaccine into dendritic cells enough to activate immune responses (vaccine delivery) [33] is 
expected. 
 
   Overall, although determining the most feasible ferrite nanoparticles is difficult due to the 
involvement of many factors for effective hyperthermia, control of magnetic properties by the 
control of the occupation of the A- and B-sites by transition metal cations (M2+ and Fe3+) in spinel 
structure should be significant for increase in therapeutic effect of magnetic hyperthermia. 
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Chapter 5 
 
Application of Fe3O4 nanoparticles to cell-separation technology using 
microalgae 
 
 
5.1 Introduction 
 
   As an example of applications of ferrite nanoparticles, magnetic cell separation was discussed 
in this chapter. As described in chapter 1, ferromagnetic nanoparticles are required for effective 
cell separation. Hence, 40-nm Fe3O4 nanoparticles were employed in this chapter. The 
motivations of this chapter are (i) to recover cells from the mixture magnetically (to form flocs of 
nanoparticles and cells) and (ii) to remove nanoparticles from the flocs. In this study, (i) and (ii) 
were carried out using microalgae. 
 
   Microalgae are a diverse group of unicellular, aquatic, photosynthetic organisms [1]. They 
have attracted intensive research and development for the production of high-value added 
products such as biofuels, animal feedstock, recombinant proteins, drugs and chemicals, through 
solar energy harvesting and carbon dioxide fixation [1-10]. For example of recent research, gene 
delivery into microalgae using hollow microneedle array was demonstrated [11], which will 
contribute to future strategy of algae-based industry. However, the high cost associated with the 
platforms for microalgal biomass production is a significant obstacle for practical 
commercialization [12]. Harvesting is one of the key elements of microalgal technology that has yet 
to be optimized for improved economics and efficiency [13]. Various approaches are used for 
harvesting microalgae, such as centrifugation, flocculation, filtration and flotation [14,15]. Of 
these approaches, flocculation is a unique method that can be combined easily with other 
approaches to enhance the speed and efficiency of separation [16,17]. This is especially appealing 
for microalgal harvesting, where the low cell concentration (few grams per liter) and the small 
cell size (typically in the order of a few μm) present a serious challenge for effective separation 
[18]. 
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Flocculation is generally achieved by adding flocculants (or coagulants) that disrupt the 
repulsive force between particles and allow binding to occur to form flocs [19]. For microalgal 
cells the repulsive force is electrostatic, due to the surface charge of microalgal cells that are 
typically negative at physiological conditions [16]. Recently, magnetic nanoparticles (NPs) with 
positive surface charge have attracted interest as promising flocculants that rapidly adsorb onto 
the microalgal surfaces, form flocs, and enable rapid, efficient microalgal harvesting through an 
external magnetic field [14,20]. 
 
   Important to the success of this magnetic nanoparticle technology is an effective and efficient 
method for removing the nanoparticles from the microalgae after harvesting, to prevent 
contamination of the biomass product [19,21]. However, limited studies have been reported to 
date on the approaches to remove NPs from microalgal flocs. This includes dissolution of the 
nanoparticles with acid [22], mechanical detachment by ultrasonication or stirring [23,24], and 
alteration of the electrostatic force by changing the solution pH [25]. An elegant approach was 
recently reported by Lee et al. and Ge et al. that applies differences in the surface tension of the 
NPs and microalgae cell surface to adsorb/desorb the NPs from the cell at will [26,27]. Although 
effective, these methods require complex/expensive steps and/or apply toxic chemicals that can 
increase the economic cost of the process and raise environmental concerns. 
 
   To overcome the issues, this chapter focused on a simple, one-step procedure that applies 
sedimentation-force through a high-density solution to separate NPs from microalgae after 
flocculation. The concept is demonstrated for the first time using a model system, where 
Chlamydomonas reinhardtii (C. reinhardtii) wild-type cells were flocculated with as-prepared 
Fe3O4 NPs. Also, NPs adsorption to microalgae is described. To adsorb/desorb effectively, ~40-
nm Fe3O4 NPs and spermine were employed as magnetic NPs and as a coating molecule of NPs. 
A commercially available, high-density solution (Percoll®) was applied to induce the separation 
during sedimentation. NP separation was investigated under different solution pH using either 
centrifugal or magnetic force, and the cell viability after each procedure was assessed with a 
fluorescence-based assay. 
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5.2 Experimental 
 
Synthesis of magnetite nanoparticles 
 
Fe3O4 NPs with a diameter of 40 nm were synthesized by the same method described in the 
chapter 2. Briefly, 50 mL of aqueous solution containing 0.125 M of spermine (Sigma-Aldrich 
Japan, Japan) was prepared as base and protective reagent for NP synthesis. 50 mL of 0.05 M of 
FeCl2·4H2O (Kanto Chemical Co. Ltd., Japan) aqueous solution was added to the spermine 
solution and stirred for 4 h at room temperature. The resulting black precipitate of Fe3O4 NPs was 
collected, washed with water and ethanol, and dried before use. 
 
Microalgae cultivation 
 
CC124 cells, a catalogue for the wild-type strain of C. reinhardtii microalgae, were obtained 
from the Chlamydomonas Resource Center at the University of Minnesota. All chemicals were 
used as received from Fisher Scientific, unless stated otherwise. CC124 cells were grown in 10 
mL of TAP media that was rocked in 50 mL Erlenmeyer flasks under moderate light [28]. The 
cells were collected during exponential growth phase, and when the concentration reached 5.0 × 
106 cells/mL. Cell counting was performed using a TC20 cell counter (Bio-Rad, USA). 
 
Zeta potential measurement and NP adsorption to CC124 cells 
 
   NPs or CC124 cells were dispersed in TAP media for the zeta potential measurement. 
Approximately 2 mL of the NP or CC124 suspension was assessed with electrophoretic light 
scattering, using a 90 Plus Zeta Particle Size Analyzer (Brookhaven Instruments Corporation, 
USA). Zeta potential was calculated using the properties for aqueous solution pre-recorded in the 
instrument software: i.e., 0.890 cP, 1.330, and 78.54 for the viscosity, reflective index and 
dielectric constant, respectively.  
   To adsorb the NPs to CC124 cells, 1 mg of NPs and 7.5 × 106 of CC124 cells were mixed in 5 
mL of TAP culture media and stirred at 1000 rpm for 15 min. The cells were used immediately after 
NP adsorption.  
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For all experiments, the pH of the TAP media was adjusted as needed using 0.5 M HCl or 0.5 M 
KOH. 
 
Cell sedimentation 
 
   Percoll® (GE Healthcare, USA) was diluted to 35 vol% or 50 vol% with TAP media. From 
the manufacturer’s specification, the as-received Percoll® has a density of 1.130 ± 0.005 g/mL. 
Assuming the density of TAP media to be about 1 g/mL, the final density of Percoll® after dilution 
to 35 and 50 vol% is calculated to be 1.046 and 1.065 g/mL, respectively. The viscosity of TAP 
media and the diluted Percoll® solution was measured using a Cannon-Fenske Routine 
Viscometer (Cannon instrument company, USA). 1 mL of the TAP media containing 1.5 × 106 
of CC124 cells (with or without NP adsorption) was layered carefully onto 1 mL of 35 or 50 vol% 
Percoll®. The layered solution was then either centrifuged at 1500 × g or 2000 × g for 5 min, 
or placed on a ferrite magnet for 10 min to allow sedimentation. The average magnetic field of 
the magnet was measured to be 1500 Oe using a 6010 model Gaussmeter (Bell Technologies Inc., 
USA). After sedimentation, the sample was used immediately for image analysis.  
 
Cell viability assay 
 
   Fluorescein diacetate (FDA) and propidium iodide (PI) were purchased from MP Biomedicals 
Inc. and Alfa Aesar, respectively. The dye solution, which is 1 μL of 10 mg/mL FDA in dimethyl 
sulfoxide and 10 μL of 1 mg/mL PI in water, was added into 1 mL of TAP media containing 1.5 
× 106 of CC124 cells (with or without NP adsorption), and incubated for 20 min. After incubation, 
the cells were imaged immediately with a fluorescence microscope to assess their viability. 
 
Image analysis 
 
   The samples were imaged with an epifluorescence microscope (Axio Imager M2m Motorized 
Microscope, Carl Zeiss, Germany). ImageJ software from NIH was used to analyze the obtained 
images [29]. One hundred particles (either individual cells, flocs or background contamination) 
were investigated to assess the distribution of particle size and the relative adsorption quantity, 
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𝑄rel, which we define here as: 
 
Equation 1   𝑄rel = (𝐴projected − 𝐴red) 𝐴red⁄  
 
where 𝐴projected is the projected area of an arbitrary particle, and 𝐴red is the projected area of 
red fluorescence observed within that particle. Histogram data was fitted to a Gaussian 
distribution using Origin software (OriginLab Corporation, USA). 
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5.3 Flocculation of nanoparticles and microalgae 
 
   Flocculation is induced by four major mechanisms: double-layer compression, sweep 
flocculation (or colloid entrapment), adsorption-induced charge neutralization, and adsorption-
induced interparticle bridging [30]. Double-layer compression is a function of the ionic 
concentration of the solution. Since the ionic concentrations of the solution between our samples 
are comparable, the effect of double-layer compression is expected to be minimal. Sweep 
flocculation is also not expected due to the absence of chemical precipitation, and hence the two 
adsorption-induced mechanisms are the dominant mechanisms of flocculation in this study’s 
system. 
Adsorption of NPs to CC124 cells can occur through concurrent contributions of van der 
Waals, dielectric, and electrostatic forces [31]. In particular, it has been shown that electrostatic 
force is the major force that determines the interaction between the cells and freshwater 
microalgae (e.g., CC124) and NPs [32]. Electrostatically-controlled flocculation is commonly 
accomplished by changing the zeta potential of NPs, 𝜁NP, and microalgae, 𝜁algae, with solution 
pH [20]. Flocculation of NP-adsorbed CC124 cells is expected to be the most significant when 
attractive electrostatic force is at maximum (i.e., sum of the magnitude of the zeta potential, ∑|𝜁|, 
is maximum at ζNP𝜁algae < 0), and the least effective when repulsive electrostatic force is 
maximum (i.e., maximum ∑|𝜁| at ζNP𝜁algae > 0). 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1 Effect of pH on zeta potential of Fe3O4 NPs and CC124 cells. Reprinted with permission. 
Copyright @ 2016 Elsevier B. V. 
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   Fig. 5.1 plots the zeta potential of NPs and CC124 cells as a function of solution pH. 𝜁NP 
was generally more positive than 𝜁algae. The positive 𝜁NP observed below the isoelectric point 
(IEP) of pH 8.8 is attributed to the protonation of amine groups from spermine molecules coating 
the NPs. The negative 𝜁NP above IEP have been attributed to the formation of FeO–O
– groups 
[22,33]. pH has also been reported to effect the protonation of the functional groups on microalgal 
cell surface and thereby change 𝜁algae [22,34]. Indeed we observed change in 𝜁algae with pH 
with IEP at pH 6.3. Based on Fig. 5.1, the strongest NP-CC124 adsorption is expected to occur at 
pH 7.0, and the weakest at pH 2.4. 
 
   Optical microscope images were taken to assess the effect of electrostatic force on NP-CC124 
flocculation (Fig. 5.2). Figure 5.2a are images from CC124 cell solution containing no NPs 
(control). The top row shows auto-fluorescence (colored red) from the chlorophyll of CC124 cells. 
The chlorophyll is also observed in the transmitted light image as dark grey particles (Fig. 5.2a, 
second row). The grey particle that does not overlap with a red fluorescence (highlighted with a 
circle) is an artifact, and in the control sample, it depicts the background impurity inherent to the 
experiment. 
   Fig 5.2b and c are images of CC124 cells after stirring in NP-containing TAP media, at pH 
2.4 (weak binding) and 7.0 (strong binding), respectively. In the transmitted light images, the 
opaque NPs form sub-micron sized aggregates, and are observed as black particulates with no 
fluorescence. It is confirmed from the transmitted light images that, in contrast to Fig. 5.2a, the 
CC124 cells in Figure 2b and c are coated by black NP aggregates, and forming flocs bigger than 
the naked CC124 cells. In particular, the larger flocs at pH 7.0 showed multiple CC124 clusters 
embedded within a matrix of NPs, indicating significant interparticle-bridging between 
negatively-charged CC124 cells and positively-charged NPs. 
   To gain a quantitative measure of this observation, a histogram of the projected area of each 
particle, 𝐴projected, was prepared from the transmitted light image (Fig. 5.2, bottom row). These 
histograms delineate the effect of electrostatic force between the NPs and the CC124 cells on floc 
formation. The peak of the histogram, 𝐴peak, and the full width at half maximum of the peak 
(FWHM) were obtained by fitting the histograms to a Gaussian distribution. 
   The 𝐴peak and FWHM of the control sample (naked CC124 cells) were 127 μm
2 and 78 μm2, 
respectively. When NP-CC124 flocculation was induced at pH 2.4 and pH 7.0, 𝐴peak increased to 
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Fig. 5.2 Optical micrograph images and histogram of NP-CC124 flocculation. (a) CC124 in TAP 
media without NPs (control), (b) with NPs at pH 2.4 and (c) at pH 7.0. The first, second and third 
rows are images taken at the same location showing fluorescence, transmitted light, and 
fluorescence superimposed on transmitted light, respectively. The circles in Fig. 5.2a highlight an 
example of an artifact (particle with no fluorescence). All scale bars in the figure represent 50 
μm. The histograms in the bottom row show the size distribution of the imaged particles. Solid 
lines indicate the Gaussian distribution fit for each histogram. Reprinted with permission. 
Copyright @ 2016 Elsevier B. V. 
 
 
298 and 619 μm2, respectively, as expected from the images of the flocs in Fig. 5.2b and c. A 
 117 
 
Chapter 5 
significant increase in FWHM values (232 and 767 for pH 2.4 and pH 7.0, respectively) was also 
confirmed, which indicates the polydispersity of the floc size. 
   The relative quantity of NPs contained within individual flocs was assessed by calculating 
𝑄rel from fluorescence images (Equation 1). The 𝑄rel values were 0.0 ± 0.1, 0.7 ± 0.5 and 1.9 
± 0.8 for the control, pH 2.4 and pH 7.0 images, respectively. A 𝑄rel value of zero is equivalent 
to all flocs containing no NPs, as expected for the control sample. Values of 𝑄rel for pH 2.4 and 
pH 7.0 are significantly larger than that of the control, indicating significant adsorption of NPs 
onto CC124 cells. The 𝑄rel of pH 7.0 was the largest, indicating the effective increase in NP 
content within the flocs, again depicting the occurrence of adsorption-induced interparticle 
bridging mechanism under attractive electrostatic force. 
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5.4 Removing nanoparticles from microalgae 
 
Forces that act on centrifuged spherical particles are buoyancy force, FB, drag force, FD, and 
centrifugal force, FC [16,35]: 
 
Equation 2.   𝐹𝐵 = 𝑉𝑝𝜌𝑠 × 𝑅𝐶𝐹 
Equation 3.   𝐹𝐷 = 6𝜋𝑟𝜂𝑣 
Equation 4.   𝐹𝐶 = 𝑚𝑝 × 𝑅𝐶𝐹 
 
where 𝑉𝑝  is the volume of the particle, 𝜌𝑠  is the density of solution, 𝑅𝐶𝐹  is the relative 
centrifugal force, 𝑟 is the radius of the particle, 𝜂 is the viscosity of the solution, 𝑣 is the 
velocity of the particle, and 𝑚𝑝 is the mass of the particle. In this study, the NPs are aggregated 
and move faster than CC124 cells. This is attributed to the smaller size of the NP aggregates that 
result in smaller FB and smaller FD, allowing the NPs to move through the solution with less 
hindrance compared to the CC124 cells. 
 
Within a NP-CC124 flocculate, the differences in the net forces between NPs and CC124 cells 
during centrifugal sedimentation will induce a tensile force between the NPs and CC124 cells. 
We hypothesized that such tensile force can be used to separate NPs from adsorption-induced NP-
CC124 flocs, offering a simple avenue to recover NPs from the microalgal flocs. 
 
To test this hypothesis, a simple bi-layer setup was prepared as illustrated in Fig. 5.3a. TAP 
media containing green CC124 cells (with or without NPs) is layered above an aliquot of 
transparent Percoll®. Percoll® is a solution containing colloidal silica coated with 
polyvinylpyrrolidone and is commonly used for biological centrifugal separation. Here, it was 
used as a representative high-density solution where 𝜌𝑠 is ~1.046 g/mL (see section 5.2). 𝜂 was 
also higher than the TAP media (1.02 and 1.16 cP for TAP media and 35 vol% Percoll®, 
respectively). As depicted in Equation 2 and Equation 3, higher 𝜌𝑠 increases FB and higher 𝜂 
increases FD. Hence centrifugal sedimentation of particles through 35 vol% Percoll® will be more 
hindered compared to similar sedimentation through the TAP media. 
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Fig. 5.3 Effect of centrifugal sedimentation on cell sedimentation with and without NPs. The 
samples were centrifuged at 1500 × g with 35 vol% Percoll® for 5 min. (a) Illustration of the bi-
layer setup. (b) Images of the CC124 cells with no NPs (control), (c) NPs adsorbed to CC124 at 
pH 2.4, and (d) at pH 7.0. The right panels of (b), (c) and (d) are fluorescence images 
superimposed onto transmitted light images. All scale bars represent 50 μm. Reprinted with 
permission. Copyright @ 2016 Elsevier B. V. 
 
Fig. 5.3b shows the result from the control experiment, where NPs were not present. A distinct 
green band is observed at the interface between the TAP media and Percoll® (depicted by the 
dotted line), and microscopy images confirm the CC124 cells dispersed in this band. This 
indicates that the sum of FD and FB of the naked CC124 cells in the Percoll® layer are comparable 
or equal to FC, effectively hindering or preventing the CC124-cell sedimentation through the 
Percoll® layer. 
 
When CC124 cells with NPs adsorbed at pH 2.4 was centrifuged under the same condition 
(Fig. 5.3c), we found a black pellet at the bottom of the centrifugal tube, and a green band around 
the TAP/Percoll® interface. Fluorescent and transparent light imaging confirmed that the black 
pellet was NP aggregates with a few red (fluorescent) CC124 cells, and the green band consisted 
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only of naked CC124 cells. This result demonstrates that NPs can sediment through the Percoll® 
layer, despite the increased FD and FB, while the naked CC124 cells cannot. Furthermore, it 
indicates that the adsorption force was smaller than the tensile force induced between the NPs and 
the CC124 cells, resulting in the separation of NPs from the microalgal flocs. Indeed, 𝑄rel of the 
algae in the green layer was 0.0 ± 0.2, indicating that NPs were effectively removed from all the 
CC124 cells in the green layer using this sedimentation process. 
 
On the other hand, when NPs were adsorbed at pH 7.0, no green/transparent interface was 
observed, and instead a green-tinted black pellet was found at the bottom of the tube (Fig. 5.3d). 
This suggests that the adsorption force was larger than the tensile force, allowing the NPs to drag 
the CC124 cells through the dense Percoll® layer without disintegration (or desorption). 
Microscopy imaging of the pellet also supports this case, showing large aggregates with clusters 
of CC124 cells embedded within the NP matrix with a 𝑄rel of 1.5 ± 0.9. The difference in 𝑄rel 
before and after centrifugation indicates a decrease of about 20% in NP adsorption per floc. This 
may be attributed to the separation of NPs that were part of the floc but were located relatively 
far from the CC124 cells, and hence experienced less electrostatic attractive force with the cells. 
 
   The key to successful NP removal from microalgae using the sedimentation-based approach 
is to induce a sufficient difference in the net force between the NPs and the CC124 cells. One way 
to achieve this is to increase the 𝜂 and 𝜌𝑠 of the bottom (i.e., Percoll
®) layer. Due to the larger 
radius of CC124 cells, the effect of increased 𝜂 and 𝜌𝑠 on FB and FD are more significant than 
the NPs (see Equation 2 and Equation 3). Therefore, the CC124 cells are subjected to a larger 
increase in resistance for moving in the direction of FC, and as a result, a larger tensile strength 
between the NPs and the CC124 cells is expected to be induced. 
 
To demonstrate this aspect, an experiment similar to the one depicted in Fig 5.3 was performed, 
but using 2 mL of Percoll® with an increased concentration of 50 vol%. The higher concentration 
results in higher 𝜌𝑠 and 𝜂 of 1.065 g/mL and 1.244 cP, respectively. RCF was also increased 
from 1500 to 2000 × g to enhance the rate of separation. As expected, the control sample without 
NPs resulted in a formation of green band around the TAP/Percoll® interface, indicating that 
CC124 cells were unable to pellet down under the applied condition (Fig. 5.4a). At pH 2.4, where 
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the electrostatic force between the NPs and CC124 cells was strongly repulsive, we saw separation 
of NPs from the microalgal floc (Fig. 5.4b), consistent with what was observed for 35 vol% 
Percoll® at 1500 × g (Fig. 5.3c). However, in this modified experiment separation was also 
confirmed from the flocculation that was strongly bound by the electrostatic attractive force at pH 
7.0 (Fig. 5.4c). This confirms that sedimentation-induced tensile force through high-density, high-
viscosity solution is an effective approach to recover the ferromagnetic NPs from microalgal flocs, 
even under the physiological condition that causes strong electrostatic attraction. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4 Effect of centrifugal sedimentation on NP-CC124 flocs at 2000 × g with 50 vol% 
Percoll® for 5 min. (a) Images of the CC124 cells with no NPs (control), (c) NPs adsorbed to 
CC124 at pH 2.4, and (d) at pH 7.0. Reprinted with permission. Copyright @ 2016 Elsevier B. V. 
 
 
A similar mechanism can applied for recovering NPs from microalgal flocs using magnetic-
field-based sedimentation, which is economically more desirable for large-scale production than 
centrifugation-based sedimentation [20,36]. For the magnetic-field-based sedimentation, 
Equation 4 will be substituted by the magnetic force experienced by the particles, 𝐹𝑀 [37,38]: 
 
Equation 5.   𝐹𝑀 = 4 3⁄ × 𝑉𝑀(?⃗⃗? ∙ ∇⃗ )𝐵0⃗⃗ ⃗⃗  
 
where 𝑉𝑀 is the magnetic volume of the particle, ?⃗⃗?  is the magnetization of the particle per unit 
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volume, and 𝐵0⃗⃗ ⃗⃗  is the externally-applied magnetic field. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.5 Effect of magnetic force on separation of NPs from microalgal flocs. (a) Images of the 
CC124 cells with no NPs (control), (b) NPs adsorbed to CC124 at pH 2.4, and (c) at pH 7.0. 
Reprinted with permission. Copyright @ 2016 Elsevier B. V. 
 
 
Fig. 5.5 are images of cuvettes containing the TAP/Percoll® bi-layer and CC124 cells with 
and without NPs. The cuvette was placed on a ferrite magnet to induce magnetic sedimentation. 
The results were comparable with the centrifugal-sedimentation studies described above (Fig. 5.3). 
The control sample formed a distinctive green/transparent interface at the surface of the Percoll® 
layer, indicating little penetration of green CC124 cells into the Percoll® (Fig. 5.5a). NP-CC124 
flocs formed at pH 2.4 were disintegrated into a green layer above Percoll® and a black precipitate 
at the bottom of the vial. This confirms that magnetically-induced tensile force is also an effective 
approach to recover the ferromagnetic NPs from the microalgal flocs. However, a green 
TAP/Percoll® interface was not observed at pH 7.0, and the majority of the green cells were 
magnetically pulled down to the bottom of the vial. This may be attributed to the smaller FM 
relative to the FC applied in Fig. 5.4, and could be circumvented by using a different magnet with 
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higher FM, or further increasing the 𝜌𝑠 and 𝜂 of the high-density layer solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.6 Effect of NPs and sedimentation treatments on CC124 cell viability (pH 7.0). Reprinted 
with permission. Copyright @ 2016 Elsevier B. V. 
 
 
Finally, we investigated the effect of NP adsorption and Percoll®-layered sedimentation on 
CC124 cell viability using the well-established FDA/PI dual fluorescence assay (Fig. 5.6) [11]. 
Briefly, FDA fluoresces when exposed to viable cells, and PI fluoresces when exposed to dead 
cells. The column in Fig. 5.6 correspond to the left ordinate and indicate the percentage of cells 
that showed fluorescence from FDA and not from PI (Equation 6). 
 
Equation 6. 
Viability (%) =
Number of FDA positive and PI negative cells
Number of total cells 
× 100 
 
The points in Fig. 5.6 correspond to the right ordinate and indicates the ratio between the initial 
viability (before exposure to NPs) and the viability after the step indicated in the abscissa 
(Equation 7). 
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Equation 7.  
Relative viability (−) =
Viability after specified step
Viability before NP exposure
 
 
where the viability before NP exposure was 98%. From the figure, it is confirmed that the 
cytotoxicity of NP adsorption, centrifugal and magnetic sedimentation, and exposure to the 
Percoll® was minimal (viability > 96%) and the majority of the cells stayed viable throughout the 
whole process. 
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5.5 Conclusion 
 
   This research demonstrates that sedimentation through a higher-density, higher-viscosity 
solution than cell media enables effective removal of Fe3O4 NPs from microalgal flocs. First, the 
flocs of nanoparticles and cells were successfully formed using an attractive electrostatic 
interaction between them. The larger-sized CC124 cells experience larger drag and buoyancy 
force than the smaller-sized NPs, which induces tensile force between the NPs and CC124 cells. 
When the tensile force overcomes the attractive forces forming the floc, NPs detach and form 
pellets at the bottom of the solution, while CC124 cells float as a green band mid-way in the 
solution. Sedimentation by both centrifugal and magnetic (just at pH 2.4) forces achieved NP 
removal, and the cytotoxicity of this procedure on CC124 cells was below 4%.  
 
 
 
 
 
 
 
 
 
 
Fig. 5.7 Figure conclusion in chapter 5. Reprinted with permission. Copyright @ 2016 Elsevier 
B. V. 
 
   Figure conclusion was shown in Fig. 5.7. This approach offers significant opportunity for 
purifying microalgal biomass after nanoparticle-flocculation-based harvesting, and for decreasing 
the cost of microalgal biotechnology. This may also find avenues in other applications that applies 
flocculation; such as algal biofilm formation in photobioreactors and wastewater treatment. As a 
future work, separation of NPs from microalgal flocs by magnetic force at pH 7 should be 
achieved. Of which, using a magnet with stronger magnetic properties and using NPs with a 
higher coercivity such as CoFe2O4 instead of Fe3O4 may be effective approaches.  
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General Conclusion 
 
 
   The motivation and results of this thesis are summarized below. The schematic illustration of 
my approach in this thesis is shown in Fig. 6.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.1 Schematic diagram of this thesis 
 
 
   In chapter 1, the background of this thesis research was described. The objective of this thesis 
is design of ferrite nanoparticles suitable for magnetic hyperthermia. Iron oxides such as -Fe2O3 
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or Fe3O4 nanoparticles (MNPs) are used as heat generators as they have the advantages of high 
biocompatibility and relatively large magnetization but commercially-used particles does not 
generate sufficient heat for cancer cell death. To overcome the issue, taking advantages of the 
previous findings of T. Osaka and his group, this thesis focused on two important points in the 
design of ferrite nanoparticles for effective magnetic hyperthermia. One is to understand the 
interactions of nanoparticles and cells. The other is to control magnetic and surface properties of 
nanoparticles. Furthermore, as an example of applications of ferrite nanoparticles, the control of 
magnetic properties appropriate to cell separation was also discussed in this thesis.  
 
   In chapter 2, to understand the effect of nanoparticles on cells, induction of cell death by 
synthesized MNPs was investigated in mesothelioma cells. Mesothelioma was targeted since 
there is little effective treatment for mesothelioma. From this chapter, there are three novel 
findings in the interaction of MNPs and mesothelioma cells, which are that (i) the specific 
apoptotic effect of MNPs on biphasic mesothelioma MSTO-211H cells was observed without AC 
magnetic field, (ii) high degree of cell mortality in all three major histological subtypes of 
mesothelioma was induced with AC magnetic field, and (iii) cellular uptake of MNPs was 
suggested to be important to induce cell death effectively under AC magnetic field. 
 
   In the first of chapter 3, as a part of the approach of understanding the interaction in detail 
between MNPs and cells, cell damage induced by cellular uptake of MNPs was discussed in 
human breast cancer cells. In the second of chapter 3, design of surface property of MNPs 
associated with selectivity to cancer cells and combination with photodynamic therapy for in vivo 
application was discussed. Control of their magnetic property appropriate to the applied condition 
of AC magnetic field was also considered. As a result, the designed MNPs showed high potential 
of desirable approach for successful application of MNPs to magnetic hyperthermia, from in vivo 
experiments using melanoma. 
 
 
   In chapter 4, as a design of nanoparticles for effective magnetic hyperthermia, control of 
magnetic properties of MFe2O4 nanoparticles for increase in heating efficacy was focused. 
Synthesis and characterization of CoFe2O4 and MgFe2O4 nanoparticles was examined. Through 
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the comparison of heating efficacy of each ferrite nanoparticles, the significance of showing larger 
magnetization and larger coercivity in the range of applied magnetic field was suggested. 
Furthermore, the in vitro evaluation of interactions between CoFe2O4 and MgFe2O4 nanoparticles 
and breast cancer cells was discussed. Although many factors such as cellular uptake and 
biocompatibility were also involved for achieving effective magnetic hyperthermia, the control 
of the occupation of the A- and B-sites by transition metal cations (M2+ and Fe3+) in spinel 
structure should be a key for further design in future. 
 
   In chapter 5, for practical use of microalgae which produce biofuels, sedimentation-induced 
detachment of MNPs from microalgal flocs using a dense/viscous solution (Percoll®) was 
discussed. Through this study, ferromagnetic ferrite nanoparticles synthesized in this thesis was 
suggested to have high potential for applying to cell separation technology. 
 
   Through all chapters, the significance of control of magnetic and surface properties of ferrite 
nanoparticles for their successful bio-application was examined and discussed. Especially, 
controlling of magnetic properties of ferrite nanoparticles appropriate to the applied condition of 
AC magnetic field and evaluation of the effect of nanoparticles on cells were focused. As a result, 
design of ferrite nanoparticles with considering (1) showing larger magnetization and larger 
coercivity in the range of applied magnetic field, (2) combination with other effects such as 
specific-cytotoxicity and photodynamic therapy, and (3) increase in cellular uptake specific to 
cancer cells, will help to achieve effective magnetic hyperthermia in future. 
   Considering to the association of each chapters of this thesis as shown in Fig. 6.1, the study 
of their combination is very interesting. As future works, mesothelioma and melanoma therapy 
using MFe2O4 nanoparticles with larger magnetization and larger coercivity in the range of applied 
magnetic field are ones of candidates. 
 
 132 
 
List of Achievements 
List of Achievements 
 
1. Original articles 
 
Sedimentation-induced detachment of magnetite nanoparticles from microalgal flocs 
Bioresource Technology, 200, 914-920, (2016) 
S. Matsuda, A. R. Durney, L. He, H. Mukaibo 
 
 
Induction of cell death in mesothelioma cells by magnetite nanoparticles 
ACS Biomaterials Science & Engineering, 1, 632-638, (2015) 
S. Matsuda, A. Hitsuji, T. Nakanishi, H. Zhang, A. Tanaka, H. Matsuda, T. Osaka 
 
 
Synthesis of cobalt ferrite nanoparticles using spermine and their effect on death in human 
breast cancer cells under an alternating magnetic field 
Electrochimica Acta, 183, 153-159, (2015) 
S. Matsuda, T. Nakanishi, K. Kaneko, T. Osaka 
 
 
Stimuli-responsive magnetic nanoparticles for tumor-targeted bimodal imaging and 
photodynamic/hyperthermia combination therapy 
Nanoscale, 8, 11625-11634, (2016) 
K. S. Kim, J. Y. Kim, J. Y. Lee, S. Matsuda, S. Hideshima, Y. Mori, T. Osaka, K. Na 
 
 
  
 133 
 
List of Achievements 
2. International conferences 
 
Effect of heating with magnetite nanoparticles on death of human breast cancer MCF-7 cells 
3rd DGIST-WASEDA Workshop on Electrochemistry, Tokyo, Japan, (December 2015) 
K. Kaneko, S. Matsuda, T. Nakanishi, H. Zhang, T. Osaka 
 
 
Cytotoxic effect of magnetite nanoparticles on mesothelioma cells 
The 6th NIMS/MANA-Waseda University International Symposium, Tokyo, Japan, (July 
2015) 
S. Matsuda, T. Nakanishi, E. Nakajima, H. Zhang, A. Tanaka, H. Matsuda, T. Osaka 
 
 
Effect of heating with magnetite nanoparticles outside and inside of cells on death of human 
breast cancer MCF-7 cells 
Conference for BioSignal and Medicine 2015 (CBSM2015), Fukushima, Japan, (July 2015) 
K. Kaneko, S. Matsuda, T. Nakanishi, E. Nakajima, H. Zhang, T. Osaka 
 
 
Synthesis and characterization of CoFe2O4 nanoparticles for application to magnetic 
hyperthermia 
10th International Symposium on Electrochemical Micro & Nanosystem Technology, 
Okinawa, Japan, (November 2014) 
S. Matsuda, T. Nakanishi, T. Osaka 
 
 
Comparison of heat generation between CoFe2O4 and Fe3O4 nanoparticles under AC 
magnetic field 
2nd DGIST-WASEDA Workshop on Electrochemistry, Deagu, Korea, (August 2014) 
S. Matsuda, T. Nakanishi, T. Osaka 
 
 
Cytotoxicity of magnetite nanoparticles on mesothelioma cells 
The 6th International Workshop on Advanced Electrochemical Power Sources, Tianjin, 
China, (December 2013) 
S. Matsuda, T. Nakanishi, H. Zhang, A. Tanaka, H. Matsuda, T. Osaka 
 
 
Cellular Uptake of Magnetite Nanoparticles and Induction of Cell Death in Mesothelioma 
Cells 
The 64th Annual Meeting of the International Society of Electrochemistry, Querétaro, 
Mexico, (September 2013) 
S. Matsuda, T. Nakanishi, H. Zhang, A. Tanaka, H. Matsuda, T. Osaka 
 
 134 
 
List of Achievements 
Induction of Cell Death and Uptake in Mesothelioma Cells by Magnetite Nanoparticles 
The 11th International Conference on Ferrites (ICF-11), Okinawa, Japan, (April 2013) 
S. Matsuda, H. Zhang, T. Nakanishi, A. Tanaka, H. Matsuda, T. Osaka 
 
 
3. Domestic conferences 
 
上皮型及び混合型中皮腫細胞にマグネタイトナノ粒子の取り込みと交流磁場印加
が及ぼす影響 
第 38 回日本分子生物学会年会，神戸，2015 年 12 月 
中嶋恵里，松田翔風，中西卓也，張弘，田中あかね，松田浩珍，逢坂哲彌 
 
細胞内および細胞外に存在するマグネタイト粒子の発熱がヒト乳がん細胞に与え
る死滅効果 
第 38 回日本分子生物学会年会，神戸，2015 年 12 月 
金子恭彩子，松田翔風，中西卓也，張弘，逢坂哲彌 
 
 
マグネタイトナノ粒子を取り込んだ中皮腫細胞への交流磁場照射が細胞死に与え
る影響 
第 37 回日本分子生物学会年会，横浜，2014 年 11 月 
日辻愛理，松田翔風，中西卓也，張弘，逢坂哲彌 
 
 
マグネタイトナノ粒子の発熱がヒト乳がん細胞 MCF-7 の生存率に及ぼす影響の in 
vitro 評価 
第 37 回日本分子生物学会年会，横浜，2014 年 11 月 
金子恭彩子，松田翔風，中西卓也，張弘，逢坂哲彌 
 
 
マグネタイトナノ粒子の中皮腫細胞への取り込みとその発熱による細胞死の評価 
第 36 回日本分子生物学会年会，神戸，2013 年 12 月 
日辻愛理，松田翔風，中西卓也，張弘，田中あかね，松田浩珍，逢坂哲彌 
 
 
中皮腫細胞に対するマグネタイトナノ粒子のアポトーシス効果 
12th Conference for BioSignal and Medicine (CBSM) 2013, 山梨, 2013 年 7 月 
松田翔風，中西卓也，張弘，田中あかね，松田浩珍，逢坂哲彌 
 
 
 135 
 
List of Achievements 
マグネタイトナノ粒子の中皮腫細胞への取り込みとその交流磁場下での発熱によ
る細胞死滅効果 
12th Conference for BioSignal and Medicine (CBSM) 2013，山梨, 2013 年 7 月 
日辻愛理，松田翔風，中西卓也，張弘，田中あかね，松田浩珍，逢坂哲彌 
 
 
中皮腫細胞へのマグネタイトナノ粒子の取り込みとその交流磁場下での発熱によ
る細胞死の評価 
電気化学会第 80 回大会，宮城, 2013 年 3 月 
日辻愛理，松田翔風，中西卓也，張弘，田中あかね，松田浩珍，逢坂哲彌 
 
 
中皮腫細胞へのマグネタイトナノ粒子の取り込みと細胞毒性作用 
第 35 回日本分子生物学会年会, 博多, 2012 年 12 月 
松田翔風，張弘，中西卓也，田中あかね，松田浩珍，逢坂哲彌 
 
 
マグネタイトナノ粒子の中皮腫細胞への取り込み及び殺傷効果の評価 
電気化学会第 79 回大会, 浜松，2012 年 3 月 
松田翔風，馬場大輔，張弘，中西卓也，田中あかね，松田浩珍，逢坂哲彌 
 
 
4. Award 
 
ICF 11 Yamazaki Yohtaro Memorial Student Award 
The 11th International Conference on Ferrites (ICF-11), Okinawa, Japan, (April 2013) 
S. Matsuda 
 
 
Key Bioenergy Article 
Renewable Energy Global Innovations, (May 2016) 
https://reginnovations.org 
“Sedimentation-induced detachment of magnetite nanoparticles from microalgal flocs” 
S. Matsuda, A. R. Durney, L. He, H. Mukaibo 
 
 
 136 
 
Acknowledgments 
Acknowledgments 
 
   I wish to extend my sincere appreciation to Prof. Tetsuya Osaka and Prof. Toshiyuki Momma 
for giving me an environment to do the research of ferrite nanoparticles for application to 
magnetic hyperthermia. I am appreciative to Prof. Toru Asahi, Prof. Takayuki Homma, Prof. 
Takuya Nakanishi, Prof. Yoshinori Nishikitani, and Prof. Kazuaki Utsumi for the referee of my 
thesis and giving me valuable advices to improve the thesis. Also Prof. Nakanishi always gave 
me many advices on my research and taught me how to give a presentation and how to make a 
document. Thank you totally for his supports. 
 
I would like to express my appreciation to Assistant Prof. Hitomi Mukaibo in University of 
Rochester for giving me an opportunity to do the research of application of ferrite nanoparticles 
to cell-separation technology. 
 
I would like to acknowledge Prof. Hiroshi Matsuda and Prof. Akane Tanaka in Tokyo 
University of Agriculture and Technology for their useful discussion and advices on my research. 
I also acknowledge Prof. Kun Na group in Catholic University of Korea for our collaboration 
research. 
 
   I deeply thanks to Prof. Keishi Ohashi, Prof. Yasurou Mori, Prof. Hong Zhang, Associate Prof. 
Shigeki Kuroiwa, Dr. Sho Hideshima, Mr. Daisuke Baba, Ms. Chigusa Shundo, Mr. Yasuhiro 
Seiko, Ms. Nanako Tsutsui, Ms. Airi Hitsuji, Ms. Rina Noguchi, Ms. Kisako Kaneko, Ms. Eri 
Nakajima, Mr. Kodai Miyazaki, Ms. Maho Kanazu, and Ms. Yuka Kashimata for their help and 
assistance on my research. 
 
   I am grateful to all members in the Applied Physical Chemistry Laboratory in Waseda 
University. 
 
   I would like to acknowledge the Leading Graduate Program in Science and Engineering in 
Waseda University for giving me many valuable experiences. 
 
 137 
 
Acknowledgments 
   Finally, I am deeply appreciative of my family for their support to concentrate on my research. 
Thank you very much totally for their cooperation. 
 
June, 2016 
Shofu Matsuda 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
